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CHAPTER 1: INTRODUCTION 
1.1 Kinase enzymes and phosphorylation 
 Kinases are a family of enzymes catalyzing the transfer of a phosphoryl group 
from a high-energy phosphoryl-donor to a substrate.9,10 In this reversible 
phosphorylation process, adenosine-5'-triphosphate (ATP) acts as the universal 
phosphoryl donor, where the γ-phosphoryl group is transferred to the target substrate 
generating the phosphorylated substrate and adenosine-5'-diphosphate (ADP) 
byproduct.11 The reverse reaction (dephosphorylation) is catalyzed by phosphatases, 
where a dephosphorylated substrate is produced (Figure 1.1).12 Due to the addition of a 
negatively charged phosphoryl group, the charge and conformation of the substrate may 
change, leading to subsequent enhancement/ inhibition of the interactions with other 
molecules. Thereby, the addition or removal of a phosphoryl group could act as a 
Figure 1.1 - General reaction catalyzed by kinases and phosphatases. The forward 
reaction is catalyzed by kinases where the γ-phosphoryl group of ATP is transferred 
to a hydroxyl or an amine group (X = -O or -NH) of the substrate molecule and ADP 
is generated as the byproduct. The reverse reaction is catalyzed by phosphatases 
where the removal of the phosphoryl group from the substrate takes place. 
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2 
molecular “on/off” switch and play a major role in a variety of biological process, 
including cell signaling, diseases, cancer, and immunosuppression.1,13 Kinases 
phosphorylate small molecule metabolites, nucleic acids, lipids, proteins and are 
typically classified according to their substrate preference. With a significant role in 
biochemical functions, it is important to understand phosphorylation.  
1.2 Protein kinases 
Phosphorylation of proteins is a vital posttranslational modification catalyzed by 
kinase enzymes. The discovery of protein kinases took place in 1950’s14 with a liver 
enzyme that phosphorylates the casein protein. Two years later the first ever isolation 
and characterization of protein kinase was performed by Krebs and coworkers15 where  
phosphorylase kinase was identified for activating glycogen phosphorylase during 
glycogen metabolism in liver. Eventually, with the discovery of cyclicAMP dependant 
Figure 1.2 – Kinase catalyzed phosphorylation of hydroxyl containing amino acids. The 
reverse reactions are catalyzed by the corresponding phosphatases. 
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3 
potein kinase  (PKA)16, it was found that kinases are not only responsible for glycogen 
metabolism, but also for other metabolic pathways and non-enzyme proteins. With the 
progressive understanding of more new kinases, it was clear that kinase-mediated 
phosphorylation of proteins plays an important role in signaling of eukaryotic cells.17,18,19  
In eukaryotic cells, kinase-catalyzed phosphorylation takes place on amino acid 
side chains containing –OH groups; namely, serine, threonine, and tyrosine (Figure 1.2). 
In humans, the relative abundance of phosphorylation on serine, threonine and tyrosine 
is approximately, 86%, 12%, and 2% respectively.20 Additionally, in prokaryotes N-
phosphorylation can take place on histidine, arginine, and lysine amino acid side chains 
as well.21 Depending on the amino acid side chain selectivity, eukaryotic protein kinases 
are divided into two major groups, serine/threonine kinases and tyrosine kinases. The 
majority of the reported protein kinases have multiple substrates, and many of the 
protein substrates can have more than one specific kinase for phosphorylation. 
Therefore protein kinases are classified based on their sequence similarity in the 
catalytic domain. According to the classification proposed by Manning and co-workers1, 
serine/threonine kinases are divided into the following groups: AGC, CAMK, CK1, 
CMGC, STE and TKL. Together with tyrosine kinases (TK) and other kinases, which do 
not belong to any of the above categories, eight main families of kinases are cataloged 
and represented on a dendrogram named the “kinome” (Figure 1.3). To date, there are 
518 members identified as human protein kinases and 1.7% of the human genome is 
encoded for protein kinases.1 In general, eukaryotes maintain 2% of their genome to 
encode protein kinases, representing one of the largest protein families.22 Due to the 
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relatively high abundance and complexity, kinase-catalyzed phosphorylation plays a 
major role in biology. The kinome forms a diverse network of signaling pathways.  
 
  
Figure 1.3 - Phylogenetic tree of all human kinases1, where TK refers to tyrosine 
kinases. Serine/threonine kinases are subdivided into: AGC (containing PKA, PKG, 
PKC families), CAMK (Calcium/calmo dulin dependent protein kinase), CK1 (Casein 
kinase 1), CMGC (containing CDK, MAPK, GSK3 and CLK families), STE (homologs 
of yeast Sterile 7, Sterile 11 and Sterile 20 kinases), and TKL (Tyrosine kinase-like). 
The other kinases are not shown in this figure. 	
TK 
TKL 
STE 
CK1 
ACG 
CAMK 
CMGC 
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1.3 The structure and kinase mechanism 
As mentioned in section 1.1, kinases deliver the γ-phosphate group from the ATP 
to the hydroxyls of the substrate. To understand the detailed catalytic mechanism of 
phosphoryl transfer reaction of kinases, the cAMP-dependent protein kinase  (PKA) is 
one of the best-studied kinase.23 Based on PKA, a general structure and mechanism for 
phosphorylation can be explained as follows. 
Protein kinases vary in the length, sequence, and structure of their N-and C-
termini, but the amino acid sequence of the ‘kinase catalytic domain' is highly 
conserved.24,25  The catalytic domain is formed by amino acids in the N-terminal and C-
terminal lobes (Figure 1.4 A). The N-terminal lobe contains about 100 amino acids, 
forming the smaller portion of the kinase domain. The shape of N-terminal lobe is 
dominated by a barrel of β-sheets and one conserved α-helix. The C-terminal lobe is 
primarily α-helical and accommodates the binding of the peptide substrate. The binding 
of ATP requires both lobes, which accommodates the nucleotide at their interface in a 
cleft called the “ATP binding pocket”. The ‘hinge region’, which connects the N- and C-
terminal lobe, is a flexible peptide chain allowing the kinase domain to change the ATP 
binding pocket.  
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The catalytic domain of protein kinases contain nine conserved amino acids: 
G52, K72, Q91, D166, N171, D184, G186, Q208, and R280 (numbering of amino acids 
are based on PKA).26 Six of the amino acids stabilize the triphosphate residue of ATP, 
while the remaining amino acids interact with the adenine base (Figure 1.3 B). During 
N-terminal lobe
C-terminal lobe
ATP binding pocket
Figure 1.4 – A) Crystal structure of the catalytic subunit of cAMP-dependent protein 
kinase (PKA) complexed with ATP and a peptide inhibitor (red) (PDB: 1ATP) B) 
Major interactions of ATP with the conserved amino acids in the active site of PKA. 
A) 
B) 
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phosphoryl transfer, ATP cosubstrate binding is stabilized by two divalent metal ions, 
either Mg2+ or Mn2+, which chelates with charged amino acid residues in the catalytic 
domain24 (the dotted lines in Figure 1.3 B shows the interactions between ATP, metal 
ions and the amino acid side chains). Aspartate (D166) deprotonates the hydroxyl group 
of the protein substrate, while the ATP molecule is positioned in the active site, such 
that nucleophilic attack on the phosphate will take placeby the hydroxyl group of the 
protein substrate (Scheme 1.1).  
 
Phosphoryl transfer can occur through either an associative or a dissociative 
mechanism (Figure 1.5).24, 27 In the dissociative mechanism, the cleavage of the bond 
between the phosphorus center and the leaving group (ADP) oxygen would take place 
first, leading to the bond formation with the attacking nucleophile (similar to SN1 type). 
On the other hand, in associative mechanism, the   bond   formation   between   the   
attacking nucleophile and the phosphorus center takes place while the leaving group 
(ADP) is still attached to the phosphorus center (similar to SN2 type). The dissociative 
mechanism is the preferred pathway for most kinases.28  
Scheme 1.1 – Mechanism of protein phosphorylation illustrated with a serine/ threonine 
amino acid, forming a phosphorylated product. 
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1.4 Enzyme promiscuity of post-translational modifications  
 Crystallographic analysis of numerous enzymes catalyzing post-translational 
modifications (PTM) shows that the enzymes would promiscuously accept structurally 
similar cosubstrates. Some of the examples include DNA methyltransferases where S-
adenosyl-L-methionine (SAM) derivatives are used to transfer diverse alkyl groups such 
as methyl, ethyl, propyl groups to DNA.29 Similarly, N-acetyltransferases30, 
transglutaminases31, farnesyl transferases32, galactosyltransferase33 etc. also exhibits 
promiscuity towards their corresponding cosubstrates. Though the promiscuous activity 
of these enzymes are generally less efficient compared to their natural counterpart, the 
understanding of promiscuous function could lead to the discovery of the relationships 
with common ancestor34 as well as novel tools in understanding biological processes.  
Figure 1.5 – Associative vs. dissociative phosphorylation mechanism for kinases. In the 
associative mechanism the leaving group and incoming nucleophile remain attached to 
the reactive, while the leaving group departs in advance of nucleophile attack at the 
reactive center in a dissociative mechanism.  
P
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P
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1.4.1 ATP-γS as a kinase cosubstrate 
 Although the promiscuity of kinase inhibitors35,36 are widely studied, the 
promiscuity of the phosphoryl donating cosubstrates is poorly explored. The first 
reported ATP analog was ATP-γS where the γ phosphoryl group is substituted by a 
thiophosphoryl group (Scheme 1.2). As shown in scheme 1.2, ATP-γS was employed 
by the kinase to transfer a thophosphoryl group to the substrate.37 When comparing the 
catalytic efficiencies, ATP-γS exhibited lower values compared to natural ATP, which 
was named as the thio-effect.38,39,40 
Although the catalytic efficiency is low for ATP-γS cosubstrate, 
thiophosphorylation has been widely used in studying kinases. The first use of ATP-γS 
was to understand the stereochemical course of hexokinase, pyruvate kinase, and 
glycerokinase, where the products were analyzed by 31P NMR and mass 
spectroscopy.41 Later on, kinase catalyzed thiophosphorylation was employed to 
chemoselectively alkylate kinase substrates.42 After kinase-mediated 
thiophosphorylation by ATP-γS, in situ alkylation was performed by iodoacetamides 
linked to a fluorophore43, a biotin44 group or a resin45. Also, thiopyridyl disulfide resins46 
and immunoaffinity purification47 were combined with thiophosphorylation for kinase-
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Scheme 1.2 – Kinase catalyzed thophosphorylation with ATP-γS, where serine, 
threonine, or tyrosine side chains are thiophosphylated on protein or peptide 
substrates. 
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substrate identification and protein purification. Shokat and coworkers have developed a 
method where an ATP-γS modified analog was used for selective phosphorylation with 
specific kinases.48,49 The ATP analog was designed with the γ-phosphoryl group 
substituted by a thiophosphoryl group and modifications on the adenine base as well. 
The kinases were mutated so that the particular kinase would selectively accept the 
base modified ATP-γS analog as a cosubstrate. Due to the selective mutation of these 
“analog-sensitive kinases” (as-kinases), the base-binding pocket was altered such that 
the bulky ATP analog were tolerated as the phosphoryl donor.50 Only the substrates 
associated with the mutated kinase will get thophosphorylated and purification/ MS 
analysis was performed for the characterization of the substrates. 
1.4.2 ATP-cosubstrate promiscuity of kinases 
When considering the crystal structure of various kinases, the ATP cosubstrate 
binds to the kinase in such a way that the γ-phosphate is bound towards the solvent 
exposed region of the kinase active site. Therefore, the Pflum lab proposed that, in 
addition to ATP-γS, ATP analogs with bulky substituents on the γ phosphate could also 
be tolerated as a kinase cosubstrate. When the γ-phosphate modified ATP analog is 
accepted as a cosubstrate, the bulky substituent will be positioned in the solvent 
exposed area and get successfully transferred to the substrate, along with the 
phosphoryl group. This property was named “ATP-cosubstrate promiscuity” and was 
successfully employed with numerous protein kinases.51,52 The γ-phosphate was 
modified with various functional groups and their function will be discussed in detail in 
the following sections. Although the phosphorylthiol approach with ATP-γS can be 
		
11 
employed to introduce functional groups (biotin, fluorophore or photocrosslinker group) 
to the thophosphorylated substrate, it requires a two-step reaction for the 
chemoselective alklation. But with the approach proposed by our lab, a functional group 
can be directly transferred from the modified ATP analogs and the kinase-catalyzed 
reaction can be employed to probe the substrate.  
1.4.3 ATP-biotin as a kinase cosubstrate 
 To validate the tolerance of γ-phosphate modified ATP analogs as kinase 
cosubstrates, a biotinylation reaction was developed using ATP-biotin as a 
cosubstrate.51 Before the Pflum lab work, the first application of ATP-biotin was reported 
on a colorimetric approach where kinase activity assay using CaMKII and PKA protein 
kinases. Gold nanoparticles capped with a peptide were used as substrates and, after 
kinase-mediated phosphoryl biotinylation, the modified substrate were mixed with 
avidin-linked gold nanoparticles. Due to the aggregates formed by the biotin-streptavidin 
interaction, resonance light scattering would take place, changing the color of the 
reaction.  
 But more elaborated work was done by Pflum lab where ATP-biotin was used as 
a general tool in studying kinases.51,53 The compatibility of ATP-biotin was studied with 
recombinant kinases as well as cell lysates (Scheme 1.3). Peptides containing serine, 
threonine and tyrosine (LRRASLG, RRREEETEEE, EAIYAAPFAKKK peptides 
respectively) were reacted with ATP-biotin in the presence of their corresponding 
kinases, PKA, CK2, and Abl. The biotinylation reactions were compared with ATP-
mediated phosphorylation control reactions and quantitative mass spectrometry (QMS) 
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analysis was performed. The ATP reaction was considered to be 100% complete and 
the relative conversion percentages were calculated for biotinylation reaction. 
Successful biotinylation was obtained for all three kinases, PKA, CK2 and Abl, with 
79%, 56% and 80% conversions, respectively. Moreover, biotinylation of full-length 
proteins by recombinant kinase (β-casein and CK2 kinase) was performed and 
analyzed via gel electrophoresis followed by biotin visualization with SA-HRP 
(Streptavidin-horseradish peroxidase) conjugate of the western blot. The QMS analysis 
of trypsin digested product showed that the efficiency of biotinylation of β-casein full-
length protein by CK2 kinase was 73% relative to the corresponding ATP reaction. In 
addition to the in vitro labeling by specific recombinant kinases, endogenous substrates 
in HeLa cell lysates were labeled by ATP-biotin with cellular kinases.  
The latest study from our lab was performed with twenty-five kinases throughout 
the protein kinase family and the compatibility with ATP-biotin labeling was analyzed.54 
Quantitative analysis and kinetic measurements indicated that all twenty-five kinases 
accepted ATP-biotin as a cosubstrate. Also, a cell permeable ATP-biotin analog, “ATP–
polyamine–biotin” was developed in our lab and successfully used for in cellulo 
Scheme 1.3 – Kinase catalyzed biotinylation with ATP-biotin, where serine, threonine, or 
tyrosine side chains are biotinylated on protein or peptide substrates by the 
corresponding kinases. 
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labeling.55 By replacing the polyethylene glycol (PEG) linker of ATP-biotin with a 
positively charged, polyamine (methylated spermine) linker, the negative charge on the 
triphosphate group of ATP was neutralized.  Thereby, under physiological conditions, 
the overall charge of the ATP analog is partially quenched and cell permeability was 
promoted. With the generality of ATP-biotin as a cosubstrate, kinase-catalyzed labeling 
provides a powerful tool for phosphoproteomics research and characterization of the 
role of phosphorylation in diverse biological events.  
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1.4.4 ATP-dansyl as a kinase cosubstrate  
 Modification of the γ-phosphate of ATP with a fluorophore provides a tool to 
transfer a fluorescent tag to the substrate of interest. With the successful use of ATP-
biotin, our lab was interested in using ATP-dansyl as a cosubstrate for kinase mediated 
fluorescent labeling (Scheme 1.5).56 Similar to ATP-biotin, PKA, CK2 and Abl 
recombinant kinases were used for the dansylation of corresponding peptide substrates. 
Quantitative mass spectrometric analysis confirmed that ATP-dansyl is also 
successfully accepted as a cosubstrated by the three kinases, PKA, CK2 and Abl, with 
91%, 81% and 87% conversions, respectively. Based on kinase-catalyzed dansylation, 
a fluorescence resonance energy transfer (FRET) based activity assay was developed 
to study the effect of kinase inhibitors.	 N-terminal rhodamine-modified peptides were 
used as the kinase substrates and upon kinase-catalyzed dansylation, the two 
fluorophores would position appropriately for FRET.56 The change in the fluorescence 
emission was used to assess the effect of kinase inhibitors.  
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1.4.5 ATP-photocrosslinker analogs as kinase cosubstrates  
 In addition to biotin and dansyl modified ATP, our lab has developed ATP 
analogs where a photocrosslinker is attached to γ-phosphate of ATP (ATP-arylazide 
and ATP-benzophenone, Figure 1.7).57,58 When arylazides are irradiated with UV light 
(254-400 nm) loss of a molecule of N2 produces a nitrene intermediate which could 
react with C-H and hetero atom (X)-H bonds (X = O, N, S) of the kinase or can undergo 
ring expansion to form a long lived intermediate ketenimine, which reacts with 
nucleophiles. For benzophenones, when UV light (350-360 nm) is irradiated, a diradical 
species will be formed, which participates in crosslinking reactions by inserting in C-H 
and X-H (X = O, N, S) of the kinase. When ATP-photocrosslinker analogs were 
incubated with a kinase and its substrate, the kinase promiscuously transferred the γ-
phosphoryl with the photocrosslinking modification to the protein/ peptide substrate. 
Upon UV irradiation, the photocrosslinker was activated and covalently binds to the 
kinase, linking the kinase with the substrate via the phosphoryl modification (Figure 
1.7).57. When the reaction mixtures were separated by SDS-PAGE followed by western 
blot analysis with an antibody, higher molecular weight bands corresponding to the 
kinase-substrate complexes were observed. This crosslinking method employs the 
natural kinase and substrate without any modifications and serves as a powerful tool in 
profiling the phosphoproteome. 
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1.4.6 Other γ-phosphate modified ATP analogs used as kinase cosubstrates 
In addition to the γ-phosphate modified ATP analogs studied in our lab 
(described in sections 1.4.3- 1.4.5), there are other reported ATP analogs used to study 
kinase activity. The Kraatz group has studied an ATP analog where the γ-phosphate of 
ATP was modified by a ferrocene group attached by a hydrocarbon linker (Figure 
1.8).59,60 This ATP-ferrocene analogs were successfully used in phosphorylation 
reactions to transfer the ferrocene-phosphate group to peptide or protein substrates. 
Electrochemical detection61 and antiferrocene antibodies (in western blot) were used for 
detection of the modified substrates and successfully used in kinase inhibitor studies. 
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 An ATP-BODIPY (Figure 1.8) analog was reported to study the activity of 
histidine kinases.62,63 The BODIPY fluorophore was attached to the γ-phosphate of ATP 
using sulfur instead of a nitrogen atom, so that the thiophosphoryl modification would 
not get hydrolyzed as fast as a phosphoramidate linked analog. ATP-BODIPY showed 
competitive binding with ATP, and was used to measure the activity of histidine kinase 
catalyzed phosphorylation. 
 Active X biosciences developed a ATP-acyl-biotin analogs (Figure 1.8) that 
crosslink with lysine residues in the nucleotide-binding region of kinases (Scheme 
1.5).64,65 The acyl-biotin group covalently reacts with lysine residues, releasing ATP, 
leading to biotinylation of kinases. Subsequent avidin purification followed by mass 
spectrometry was employed as a kinase activity assay as well as identifying other ATP 
binding proteins.  
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1.5 Significance of the projects 
 Characterization of phosphorylation events in cells plays a major role in 
understanding cellular processes. The large diversity of various roles played by kinases 
in cell signaling processes make kinases an interesting protein to study. As protein 
kinases represent the majority of the family and play an important role in post-
translational modifications, they are the most widely studied. Given the importance of 
studying kinases, the development of tools to understand kinases is in high demand. 
Previous work from our lab has contributed novel tools to study kinases, where γ-
phosphate modified ATP analogs are used to label substrates. The kinase-catalyzed 
reactions with various ATP analogs (ATP-biotin, ATP-danzyl, ATP-photocrosslinker, and 
other analogs) demonstrated that protein kinases promiscuously accept γ-phosphate 
modified ATP analogs as cosubstrates.  
 So far kinase catalyzed labeling with γ-phosphate modified ATP analogs has 
been developed only for protein kinases. In this work, our main goal is to explore 
whether non-protein kinases would also exhibit kinase cosubstrate promiscuity. In 
addition to protein kinases, lipid kinases, nucleotide kinases and carbohydrate kinases 
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are known to play a major role in cell signaling. Compared to protein kinases, the roles 
of the other kinases in biology are poorly understood. We report here the development 
of kinase-catalyzed labeling with nucleotide and lipid kinases to probe their respective 
substrates. The analysis of available crystal structures of polynucleotide and lipid 
kinases indicates that some kinases contain a similar, solvent-exposed active site like 
protein kinases. Therefore, we hypothesize that polynucleotide and lipid kinases would 
display cosubstrate promiscuity because the active sites are relatively solvent exposed 
and can accommodate the γ-phosphate modification on the ATP analogs.  
Our choice of nucleotide kinase was T4 polynucleotide kinase (T4 PNK), which is 
widely used in molecular biology for 5ʼ-end labeling of polynucleotides. In chapter 2, the 
compatibility of using ATP-biotin as a cosubstrate for T4 PNK was studied, where 
kinase-catalyzed biotinylation can be employed as a novel chemical tool to biotinylate 
the 5’-end of single / double stranded DNA or RNA. For studying the compatibility of 
lipid kinases, Sphingosine kinase 1 (SPHK1) catalyzed labeling of sphigosine substrate 
was analyzed (Chapter 3). As sphingosine and sphingosine-1-phosphate are lipids 
associate with receptors on the cell surface to initiate cell-signaling pathways, they play 
a major role in cell growth, angiogenesis and other various deceases. But due to the 
limited availability of tools, the role of sphingosine in signaling pathways is understudied. 
Thereby we study the cosubstrate promiscuity of SPHK1 to provide an unprecedented 
tool to study lipid biology. 
In this work, the objective was to rigorously characterize γ-phosphate modified 
ATP analogs as cosubstrates of T4 PNK and SPHK1. A variety of qualitative and 
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quantitative data indicated that γ-phosphate modified ATP analogs can be employed as 
a cosubstrate of non-protein kinases. These studies provide guidance for future use of 
kinase-catalyzed labeling in DNA and lipid research. 
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CHAPTER 2: STUDYING THE COSUBSTRATE PROMISCUITY OF NUCLEOTIDE  
KINASES 
In this chapter, a brief review of nucleotide kinases and previously reported 
kinase catalyzed labeling by T4 polynucleotide kinase (T4 PNK) are discussed. Also the 
synthesis of γ-phosphate-modified ATP analog, ATP-biotin, and use of the analog for 5’ 
labeling on DNA oligomers and double stranded DNA are discussed. The labeled 
products were analyzed by ADP-Glo™ kinase assay, Gel shift, Southern blot, DNA dot-
blot, and MALDI-TOF analysis. 
2.1 Introduction 
2.1.1 Introduction to Polyucleotide Kinases (PNK) 
 PNKs are ubiquitous enzymes in cells that play an important role in the repair of 
damaged DNA and RNA by endogenous or exogenous agents including, oxidative 
damage,66 ionizing radiation,67 base excision.68  Such damage to polynucleotides can 
lead to changes in replication or transcription, and result in mutations that could lead to 
cell death or changes in growth. To repair the break points by DNA/ RNA polymerases 
and ligases, the DNA or RNA strands must contain a 5′- phosphate and 3′- OH 
terminus.69    PNKs restore the appropriate 5′- phosphate and 3′- OH to allow strand re-
ligation.70 Human PNKs (hPNKs) are progressively becoming important as a potential 
target for cancer treatment because abnormal activity and mutations of hPNK are 
associated with various human diseases. 71   
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2.1.2 T4 Polynucleotide Kinase (T4 PNK) 
 T4 PNK is a commonly used reagent in molecular biology.3 It was first isolated 
from bacteriophage T4 infected Escherichia coli by Richardson and co-workers in 
1965.72 The biological function of T4 PNK is explained as follows. When host cells are 
infected by enterobacteria phage T4, the host bacteria cells attack T4 protein synthesis 
by site specifically degrading host-cell tRNAs. As a host-restriction mechanism, phage 
repairs the damaged tRNA using T4 PNK and continues to propagate.73,74  
T4 PNK is a bifunctional enzyme with both 5′- kinase and 3′- phosphatase 
activity, capable of converting 3′-phosphate to 3′- OH ends as well as 5′- OH to 5′- 
phosphate ends of broken RNA or DNA during the repair.72,75,76 Structural analysis 
shows that T4 PNK is a homotetramer of a 301 amino acid polypeptide monomer.77 
Site-directed mutagenesis studies show that the T4 PNK monomer is made up of two 
distinct N and C terminal domains where the N-terminus exhibits 5′-kinase function and 
the C-terminus contains the 3′-phosphatase function.78,8 There are two major 
differences between T4 PNK and eukaryotic PNK.79 One is that T4 PNK has an N-
terminus kinase domain and an C-terminus phosphatase domain, whereas eukaryotic 
PNK have the opposite organization where, N-terminus is the phosphatase domain and 
the C-terminus contains the kinase domain.70 The other difference is that T4 PNK is a 
140 kDa homotetramer, while the eukaryotic PNK (hPNK) is a ~60 kDa monomer.80 
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2.1.3 Applications of T4 PNK as a tool in molecular biology  
 Commercially available, recombinant T4 PNK is prepared by the cloned phage 
gene expressed in E. coli.81 The most common application of T4 PNK is to 
phosphorylate 5′ – OH ends of ss- and dsDNA, ss- and dsRNA, synthetic 
oligonucleotides and nucleoside 3’-monophosphates (forward reaction, Figure 2.1 A).82 
In the presence of excess ADP, T4 PNK exhibits 5′ - phosphatase activity and catalyzes 
the exchange of phosphoryl groups between 5′ - Phosphoryl-polynucleotides and ADP 
(exchange reaction, Figure 2.1 B).83 In this two-step process, T4 PNK will first transfer 
the 5′ - phosphorly group from the nucleic acid to ADP, forming ATP and leaving a 
dephosphorylated polynucleotide substrate. Next, PNK will complete the forward 
reaction and transfer a phosphoryl group from ATP to the target polynucleotide. Also, T4 
PNK possesses 3′ - phosphatase activity on DNA, RNA, oligonucleotides and, 3′,5′ – 
bisphosphates (Figure 2.1 C).84 However, the 3′ – phosphatase activity has only a little 
significance towards molecular biology applications.  
 In cloning, modification of the 5′ end of DNA by phosphorylation is important in to 
allow the DNA to ligate after insertion of a vector or to chemically attach a probe to the 
DNA. Custom-made synthetic oligonucleotides, lack 5′ - phosphate group, which is not 
compatible with ligation reactions. Thereby, T4 PNK is regularly used to transfer a γ-
phosphate of ATP to the 5′ – OH group to enable the ligation. The other most common 
application is radiolabeling polynucleotides with 32P for use as hybridization probes for 
blotting, DNA/RNA sequencing and gel shift experiments. Here in, [γ-32P]ATP was used 
as the phosphoryl donor.  
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2.1.4 Structural and Crystallographic analysis of T4 PNK 
 Mutational studies show that out of 301 amino acids of T4 PNK monomer, five 
amino acids from the N- terminus (Lys15, Ser16, Asp35, Arg38 and Arg126) participate 
to the 5′- kinase activity (Figure 2.2 A).3,77 Four out of five amino acids that are 
necessary for phosphoryl transfer in T4 PNK are also conserved in human80 and 
Schizosaccharomyces pombe85 PNKs, which suggests that all PNK possesses similar 
conserved binding sites and mechanism of phosphorylation. The C- terminal 3′-
phosphatase domain consists of Asp165, Asp167, Arg176, Arg213, Asp254 and 
Asp278, which are similar to phosphoglycerate mutase and acid phosphatases.8 The  
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domain boundary between the kinase and phosphatase domain is located between 
Arg126 and Asp165.77 The kinase and phosphatase active sites are ~35 Å apart from 
each other and the same distance is observed between the closest active sites from 
separate subunits of the T4 PNK tetramer (Figure 2.2 B). 
5' Kinase domain (K)5' Kinase domain (K) 3' Phosphatase domain (P)
K
K
K
K
P
P
P
P
A. 
Figure 2.2 – A. N-terminal 5′-kinase (green) and C-terminal 3′-phosphatase (blue) 
domains of T4 PNK monomer.3 B. The tetrameric form of T4 PNK8  
B. 
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2.1.5 The ATP cosubstrate promiscuity of T4 PNK 
A computational docking analysis (Autodock Vina) of the kinase domain of T4 
PNK shows that the bound ADP molecule is located on the side of the 0.2 Å ATP 
binding site, whereas the phosphate chain is directed towards the channel in the middle 
of the enzyme tetramer (Figure 2.3 A). This central channel is solvent-exposed through 
the middle of the tetramer with 15–20 Å diameter (Figure 2.2 B).8 In contrast, the crystal 
structure of adenylate kinase 1 (myokinase), which phosphorylates AMP to produce 
ADP, shows the cosubstrate buried in the active site away from solvent exposed region 
(Figure 2.3 B). Given the likely solvent exposure of the kinase domain near the γ-
phosphate of ATP, the crystal structural analysis suggests that T4 PNK could 
accommodate the binding of a bulky γ-phosphate modified ATP analog for kinase-
catalyzed labeling. 
 
A.. B.. 
Figure 2.3 – A. T4 PNK (green) in complex with ADP (red) and nucleotide substrate 
(yellow)(PDB 1RRC).4 B. Adenylate kinase 1 (green) in complex with ATP derivative, 
AMPNP (red) and AMP substrate (yellow) (PDB 1ANK).7 
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Although kinase-mediated biotinylation has been applied to protein substrates, 
application to non-protein kinases has been sparsely studied. One report documented 
T4 PNK-mediated thiophosphorylation with ATPγS, followed by in situ alkylation to 
introduce a biotin group on to an RNA/ DNA substrate in two-steps process.86 Also 5’-
end labeling of single-stranded DNA/RNA using T4 RNA ligase was performed to 
introduce a biotin group.87 Another study demonstrated use of ATP analogs with 
photocrosslinking groups to label single stranded DNA substrates.88	Furthermore, a T4 
PNK activity assay was reported where single-molecule/nanoparticle imaging was 
performed on DNA immobilized on a coverslip.89 Herein, the 5’ biotinylation of 
immobilized DNA was performed by T4 PNK where the cosubstrate consists of a biotin 
group linked to the γ-phosphate of ATP. While a γ-phosphate modified ATP was 
compatible with PNK in solid phase, polynucleotide labeling in solution phase was not 
studied.  
In this work, our objective was to use γ -phosphate modified ATP analogs as 
chemical tool to label the 5’ ends of single / double stranded DNA or RNA substrates as 
an alternative to radioactive or chemical labeling in solution phase.  Herein, ATP-biotin 
was employed as the kinase cosubstrate to transfer a phosphobiotinly group to 
polynucleotide substrates (Figure 2.4). A variety of data are consistent with ATP-biotin 
as a cosubstrate of PNK. However, the biotin group was not stable enough for DNA/ 
RNA purification.  
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2.2 Results 
2.2.1 Synthesis of ATP-biotin 
 To test whether T4 PNK can use γ-phosphate modified ATP as a cosubstrate, 
ATP- biotin (1) was synthesized, as follows.90 Biotin (4) was activated by TBTU, and 
then treated with 4, 7, 10-trioxa-1-13-tridecanediamine (5) to yield biotin amine (6) 
(Scheme 2.1). Next, biotin amine (6) was coupled with the sodium salt of ATP using 
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EDCI in water to give ATP-biotin (1), which was purified on a DEAE sephedex-A25 
anion exchange column with a step-wise elution of triethylammonium bicarbonate buffer 
(TEAB).  
2.2.2 Kinase catalyzed 5’ phosphobiotinylation of DNA 
  With the synthesized ATP-biotin (1), in vitro studies were performed to 5’-
biotinylate oligomers and double stranded DNA with T4 PNK. The products were 
analyzed by gel shift experiments, Southern blot, dot-blot, and mass spectrometric 
(MALDI-TOF) analysis to confirm the phosphorylbiotin-modification. 
2.2.2.1 ADP-Glo™ kinase assay analysis 
 The tolerance of T4 PNK to ATP-biotin was tested with a 28mer single stranded 
(ss) DNA oligonucleotide using the ADP-Glo™ assay that monitors production of the 
ADP byproduct of the phosphorytransfer reaction using a luminescence signal (Figure 
2.5).91 The ADP-Glo Kinase Assay can bel used to monitor the activity of almost any 
ADP-generating enzyme, such as a kinase or ATPase. It can be used as a high-
throughput screening method to measure kinase activity by quantifying the amount of 
ADP produced during a kinase reaction. Since 5’ phosphorylatoin by T4 PNK releases 
ADP, this method can be used to evaluate the tolerance of T4 PNK to the ATP-biotin 
cosubstrate. 
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Figure 2.5 - Theory of ADP-Glo the Assay. Kinase reactions with ATP or ATP analog 
produced ADP as a byproduct. Addition of ADP-Glo reagent inhibited the kinase 
reaction and degraded remaining ATP or ATP analog. Kinase detection reagent 
converted ADP into ATP and this newly formed ATP was used in a luciferase 
reaction to produce light. 
N
NN
N
NH2
O
OHOH
OPO
O-
O
PO
O-
O
PX
O-
O
N
NN
N
NH2
O
OHOH
OPO
O-
O
P
O-
O
-O
ATP/ ATP analog
ADP
Base
O
O
HO
Base
O
O
OPX
O-
O
T4 PNK / 
Mg2+
Polynucleotide substrate
5' labeled Polynucleotide
inhibit the kinase reaction and
degrade remaining ATP or ATP analog
ADP Glo 
reagent
Kinase detectoin 
reagent
N
NN
N
NH2
O
OHOH
OPO
O-
O
PO
O-
O
P-O
O-
O
(ADP coverted to ATP)
Luciferase/luciferin 
reaction
Luminescence
		
31 
The ADP-Glo™ kinase assay is performed in two steps. In the first step, after the 
kinase reaction, an equal volume of ADP-Glo™ reagent was added to terminate the 
reaction and deplete the remaining ATP (Figure 2.5). In the second step, the Kinase 
detection reagent is added to re-convert ADP to ATP and allow the newly synthesized 
ATP to be measured using a luciferase/ luciferin reaction. The luminescent signal 
generated is proportional to the ADP concentration produce by the kinase catalyzed 
phosphorylation or biotinylation reaction and is correlated with kinase activity towards 
ATP or ATP-biotin. 
To study the T4 PNK tolerance of ATP-biotin using the ADP-Glo™ kinase assay, 
a single stranded DNA substrate was employed, since T4 PNK shows highest efficiency 
with single-strand DNA.92 Here in, 28mer (with a sequence of 5’-GAC CGT AGG CAA 
GAG TGT GCT TTT TTT TT – 3’) was used as the nucleotide substrate. As the ATP-Glo 
assay was developed to assess kinase activity only towards ATP reactions; numerous 
control reactions were performed with ATP-biotin reactions. Controls with no ATP or 
ATP-biotin (Figure 2.6, column 2) did not produce a luminescence signal since there is 
no cosubstrate to generate ADP upon kinase reaction. Similarly, very low background 
signal was obtained in the absence of T4 PNK for ATP and ATP-biotin reactions (Figure 
2.6, columns 3 and 6 respectively) as no ADP is generated during the incubation of the 
kinase reaction. However, a high background signal was observed for ATP/ATP-biotin 
reaction with T4 PNK in the absence of the 28mer DNA substrate (Figure 2.6, columns 
4 and 7 respectively), because of background hydrolysis of ATP or ATP-biotin to ADP 
by the kinase.93 But compared to ATP, ATP-biotin gave less background due to the 
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presence of the phosphoramidate linkage. The reaction containing single stranded 28-
mer DNA substrate, T4 PNK, and ATP produced a 1.7-fold increase in luminescence 
signal compared to reactions containing no 28mer substrate (Figure 2.6, column 4 
versus 5, and Table A.1). A similar 1.5-fold signal increase was observed with when 
ATP-biotin was used as the as the cosubstrate (Figure 2.6, column 7 versus 8, and 
Table A.1), but with lower luminescence signal, suggesting T4 PNK consumes ATP-
biotin with lower efficiencies compared to natural ATP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 1 2 3 4 5 6 7 8 
28mer + + + - + + - + 
T4 PNK - + - + + - + + 
ATP - - + + + - - - 
ATP-biotin - - - - - + + + 
Figure 2.6 - ADP-Glo assay with 28mer DNA. T4 PNK, and ATP or ATP-biotin, with 
arbitrary luminescence units after 2 hr reaction. Raw data is shown in Figure A.1 
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2.2.2.2 MALDI-TOF MS analysis of phosphobiotinylated DNA 
 Matrix-assisted laser desorption/ ionization, time-of-flight mass spectrometry 
(MALDI-TOF MS) is one of the most promising mass spectrometric approaches used in 
nucleic acid analysis.94 MALDI-TOF MS is becoming one of the most popular 
alternatives to Sanger sequencing and molecular weight determination, which gives the 
advantage of faster characterization without labeling and gel electrophoresis.95,96 In 
addition to DNA, RNA, and oligonucleotide sequencing, posttranscriptional modifications 
on RNA was successfully identified by MALDI-TOF MS.97,98 Thereby, T4 PNK mediated 
labeling of 5’ ends of ssDNA could be successfully characterized by MALDI-TOF MS as 
well. 
 In MALDI-TOF MS analysis, the matrix/analyte cocrystals were generated by 
dried droplet deposition where the matrix, nucleotide analyte and the additives were 
evaporated to form uniform crystals.  For single-stranded nucleic acid molecules, the 
best choice of matrix reported is 3-hydroxy picolinic acid (3-HPA).99,100 The 
analyte/matrix crystals were irradiated by a laser to induce the desorption and 
ionization, where the ionized components pass through a flight tube connected to a 
detector. Separation of charged species occurs by the time of flight, which is 
proportional to the mass of the individual molecules. Ammonium citrate was added 
during sample preparation to avoid acidic pH during sample preparation and cation 
exchange to remove possible Na+ and K+ ions on the DNA backbone.94 In this work, to 
confirm the presence of a biotin group, a 5’-phosphobiotinylated 14mer (5’-GGG TGG 
CCT TGT CC- 3’) was used as the substrate. 
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 To observe the presence of a biotin group after kinase catalyzed biotinylation, a 
5’-phosphobiotinylated 14mer was produced in ATP-biotin reaction. The ssDNA product 
was separated from the remaining reaction components by ethanol precipitation and 
analyzed via MALDI-TOF in negative mode.101 The results showed the presence of 5’ 
phosphorylated 14mer, (calculated [M-H]— 4366.9 m/z, observed 4367.637 m/z, Figure 
2.7). The presence of a phosphoryl group instead of a phosphorylbiotin group may be 
observed due to the cleaving of phosphoramidate group during the ethanol precipitation 
or possible laser-induced fragmentation at the phosphoramidate linkage during mass 
spectrometric analysis. The MS data provide evidence that ATP-biotin is a cosubstrate 
Figure 2.7 - MALDI-TOF MS analysis of T4 PNK catalyzed 5′-biotinylation of a 14mer 
single stranded DNA (5’-GGG TGG CCT TGT CC- 3′) in negative ion mode. 5′-P-
14mer: calculated [M-H]— 4366.9 m/z, observed 4367.637 m/z; 5′-P-biotin-14mer 
calculated [M-H]—: 4795.2 m/z was not observed. 
5’-P-14mer 4367.637 m/z 
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of T4 PNK, consistent with the ADP-Glo™ data. However, the data also indicate that the 
phosphoramidate bond connecting biotin to the DNA is unstable. 
2.2.2.3 Gel shift analysis 
 With evidence showing that ATP-biotin is a T4 PNK cosubstrate, the reaction 
conversion was quantified using gel methods. Electrophoretic mobility shift assay, also 
known as gel shift analysis, was employed to quantify the biotinylated product. The rate 
of migration of the modified nucleotide product would differ from the un-biotinylated 
substrate in gel separation, as the 5’-phosphorylbiotin group would alter the charge and 
the size of the nucleotide substrate. Hence, a new gel band or a smearing of the gel 
band is expected due to the 5’-labeled product. Small ssDNA substrates (28mer and 
37mer) were used as the nucleotide substrate because a clear shift in gel migration of 
short oligomers can be observed in denaturing polyacrylamide gel (15-20% acrylamide). 
Also, to compare with the ATP-biotin reaction product, a control ssDNA with the same 
sequence and a synthetically attached 5’-biotinyl group was employed (Figure 2.8). 
Although the 5’-modification of the synthetic oligomer is not identical to the 5’-
phosphorylbiotin group attached by the kinase catalyzed reaction, the phosphoryl group, 
PEG linker, and the biotin group could show a similar migration as the kinase-catalyzed 
labeled ssDNA product.  
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Single stranded 28-mer DNA substrate was incubated with ATP-biotin and T4 
PNK to generate labeled DNA product. The crude reactions were separated by 20% 
denaturing urea gels and visualized by SYBR gold nucleic acid gel stain. Gel 
electrophoresis analysis of the reaction containing 28mer DNA fragment, ATP-biotin and 
T4 PNK produced a slower migrating product (Figure 2.9, lane 7). Similarly, the ATP-
containing reaction also formed the slower migrating product (Figure 2.9, lane 6). 
Migrations of the new products of ATP and ATP-biotin reactions were similar to the 
synthetic biotin-DNA control (Figure 2.9, lane 2). The extent of reaction conversion was 
calculated by imageJ software where the band intensities of product versus unreacted 
substrate were quantified for three independent trials. The extents of conversions are 
similar with ATP (49 ± 3%) and ATP-biotin (40 ± 2%) in all three trials, suggesting that 
T4 PNK accepts both ATP and ATP-biotin as cosubstrates. The controls with no T4 
PNK (Figure 2.9, lanes 4 and 5) and no cosubstrate (Figure 2.9, lane 3) confirmed that 
the new bands are not due to non-specific interactions between the ssDNA substrate 
and the cosubstrate or the kinase.  
H
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5' end
3' end
Figure 2.8 - Structure of the 5′-biotin group synthetically attached to the DNA fragment, 
which was used as a control in the quantitative gel, Southern blot, and dot blot analyses.  
The DNA containing this 5′- modification is labeled as “biotin-DNA”. 
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The same study was carried out on a different ssDNA with the sequence of 5’- 
GGG CTG GGG GCG CGC ACC ATG CAA AGA AGT CCG AGG C – 3’ (37mer) 
(Figure 2.9, lanes 8 to 14). A similar new band was formed with ATP (47%) and ATP-
biotin (42%) reactions (Figure 2.9, lanes 13 and 14). Similar percentage conversions for 
both ATP and ATP-biotin reactions were observed for small oligomers, 28mer and 
37mer, suggesting that the length does not significantly affect the labeling of small 
oligomers.  
2.2.2.3.1 T4 PNK labeling efficiency for different 5’ bases 
In order to see whether the 5’ base of ssDNA has an influence on biotinylation, 
the 28mer substrates with C, A, T and G bases at the 5’ end were reacted with ATP / 
ATP-biotin (Figure 2.10). The electrophoresis analysis with ATP as the cosubstrate 
showed percentage conversions as follows; 53 ± 5 % with 5’-A, 67 ± 4 % with 5’-C, 62 
 1 2 3 4 5 6 7  8 9 10 11 12 13 14 
28mer + - + + + + +  - - - - - - - 
37mer - - - - - - -  + - + + + + + 
ssDNA-biotin - + - - - - -  - + - - - - - 
ATP - - - + - + -  - - - + - + - 
ATP-biotin - - - - + - +  - - - - + - + 
T4 PNK - - + - - + +  - - + - - + + 
% Conversion - - - - - 52 45  - - - - - 49 44 
Figure 2.9- Kinase catalyzed biotinylation of the 28mer (A) and 37mer (B) with the 
controls as indicated below each lane. Other trials are shown in the appendix 
section (Figures A.5 and A.6). The DNA was visualized with SYBR Gold 
(Invitrogen). In both A and B, a synthetic 28mer containing a 5′-biotin group (ss 
DNA-biotin, Figure 2.8) was included for comparison. 
5'-P DNAè	
DNAè		
A. B. 
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± 10 % with 5’-T, and 47 ± 1% for 5’-G (Figure 2.10 and A.7). Compared to ATP, ATP-
biotin reactions exhibited lower efficiencies, with 44 ± 16 % for 5’-A, 60 ± 3 % with 5’-
C, 48 ± 8 % with 5’-T, and 43 ± 1% for 5’-G (Figure 2.10 and A.7). The percentage 
conversions for ATP reaction is not consistent with the previous studies comparing the 
efficiencies of 5’ labeling (30 minute reaction) with [γ-32P]ATP as the cosubstrate.102 The 
radiolabelling studies showed highest efficiency with G as the 5’ base and lowest when 
C is the 5’ base, while the gel quantification results did not follow the same efficiencies. 
According to the authors of the previous radioactive labeling work, there are several 
factors that influence the labeling efficiency of oligonucleotides with T4 PNK mediated 
phosphorylation, including the quality of T4 PNK, the quality or the purity of the 
oligonucleotide, the sequence of the oligonucleotide, and the quality of the cosubstrate. 
For an instance, a significance difference in enzyme activity was reported depending on 
the vendor of T4 PNK. Also, the quantification method reported in chapter 2 is based on 
gel band quantification by ImageJ software, while earlier radioactive labeling 
quantification used liquid scintillation counting via radiography. Thereby similar 
efficiencies for ATP reaction are not expected due to the differences in the assays. 
However, these results demonstrate that the ATP-biotin reaction is compatible with DNA 
substrates containing all four bases at the 5′-position, with a small preference for a 5′-T.    
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2.2.2.4 Southern blot and dot-blot analysis 
To observe the presence of the biotin group on the 5’ end after ATP-biotin 
labeling, the modified DNA was transferred to a membrane for Southern blot.  
Streptavidin-Cy5 (SA-Cy5) was employed to locate biotinylated DNA on the membrane 
by fluorescence, as streptavidin and biotin have strong interaction. The 37mer was first 
PCR amplified to produce a 417mer fragment, because for an efficient transfer to the 
nylon membrane required the size of the polynucleotide to be greater than 75 bases. 
After a 2 hr kinase reaction with the PCR-amplified 417mer fragment, the products were 
separated by 0.7% agarose gel electrophoresis, transferred to Nylon+ membrane by 
Southern blot (alkaline transfer, 8 hr) and stained by SYBR gold and SA – Cy5 to see 
the presence of all DNA and biotinylated products, respectively. Although the SYBR 
gold stained membrane shows a successful transfer of the amplified DNA to the 
membrane, SA-Cy5 visualized only the positive control with the synthetic 37mer 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
28mer 5’A  - + + + - - - - - - - - - 
28mer 5’C - - - - + + + - - - - - - 
28mer 5’T - - - - - - - + + + - - - 
28mer 5’G - - - - - - - - - - + + + 
28mer-biotin + - - - - - - - - - - - - 
ATP -  - + - - + - - + - - + - 
ATP-biotin - - - + - - + - - + - - + 
T4PNK - - + + - + + - + + - + + 
% Conversion - - 58 60  70 63  72 56  47 43 
Figure 2.10 – Kinase-catalyzed biotinylation of the 28mer with different 5’ bases. 
Second trial is shown in the appendix section Figure A.7. The DNA was visualized 
with SYBR Gold (Invitrogen). A synthetic 28mer containing a 5′-biotin group 
(Figure 2.8) was included for comparison (biotin-DNA). 
 
5'-P DNAè	
DNAè		
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containing a 5’-biotin group (Figure 2.11, lane 5). The ATP-biotin reaction resulted no 
Cy5 signal.  
  
 
 
 
 
 
 
We hypothesized that the gel separation and membrane transfer steps could 
result in a loss of the unstable biotin group. To avoid the gel separation and alkaline 
transfer, as an alternative, after performing the kinase reaction, DNA in the kinase 
reaction mixture was directly immobilized on the Nylon+ membrane by Bio-Dot® 
microfiltration apparatus. SYBR gold staining confirmed successful transfer of DNA and 
SA-Cy5 staining and showed low intensity ATP-biotin labeling (11% ±1 conversion), 
which showed evidence of 5’ phosphorylbiotinylation (Figure 2.12, lane 5). The data are 
consistent with the instability of the biotin group on DNA, but are consistent with kinase-
catalyzed biotinylation of DNA by T4 PNK. 
  
 1  2 3 4 5 
Pure 37mer amplified - + + + + 
37mer-biotin amplified + - - - - 
ATP-Biotin - - - + + 
T4 PNK - - + - + 
ATP - - + - - 
Membrane  
(SYBR gold stained) 
 
Membrane  
(SA-Cy5 stained) 
 
Figure 2.11 – Southern blot analysis of the phosphobiotinylation of PCR-amplified 
DNA. A 417-mer PCR amplified product generated using a 37-mer primer was 
subsequently reacted with the components indicated below the lane. Total DNA was 
visualized by SYBR gold stain (top) and biotin-modified DNA was visualized using a 
streptavidin-Cy5 (SA-Cy5) conjugate (bottom). Repetitive trials shown in appendix  
Figure A.8 
 
 DNAè	
 
Biotinylated DNAè 		
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2.2.2.5 Studying the stability of ATP-biotin 
The loss of biotinylation product may be due to the hydrolysis of the 
phosphoamidate bond during analytical manipulations or a kinase catalyzed secondary 
reaction where biotin amine group is removed (Figure 2.13). The phosphoramidate bond 
connecting the biotin group to the 5’-phosphoryl is prone to hydrolysis at low pH.93,103  
 
 1 2 3 4 5 6 
Pure 37mer amplified - + + + + + 
37mer tag amplified + - - - - - 
T4 PNK - - + - + - 
ATP - - + + - - 
ATP-B - - - - + + 
Membrane  
(SYBR gold stained) 
 
Membrane  
(SA-Cy5 stained) 
 
Figure 2.12 – Dot blot analysis of the phosphobiotinylation of PCR amplified DNA. 
Analysis of the 417-mer PCR amplified product generated using a 37-mer primer that 
was subsequently reacted with the components indicated below the lane. Total DNA was 
visualized by SYBR gold stain (top) and biotin-modified DNA was visualized using a 
streptavidin-Cy5 (SA-Cy5) conjugate (bottom). Repetitive trials are shown in Figure A.9. 
Figure 2.13 –Proposed degradation of the phosphoramidate bond connecting the 
biotin group to the 5′-DNA after kinase catalyzed biotinylation  
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To observe whether ATP-biotin was degrading to ATP before kinase-catalyzed 
reaction, ATP-biotin was monitored by thin layer chromatography after incubation with 
T4 PNK in kinase buffer.  No degradation of ATP-biotin to biotin amine and ATP was 
observed (Figure 2.14), showing that ATP-biotin is consumed by T4 PNK as a 
cosubstrate only in the presense of nucleic acid substrate. 
 
 
 
2.3 Discussion and conclusions 
 In this work, the ATP cosubstrate promiscuity of T4 PNK was studied to explore 
whether we can extend the use of kinase-catalyzed biotinylation to polynucleotides. The 
introduction of an affinity tag would facilitate the detection, purification or study of other 
interacting molecules. Reported PNK-mediated labeling involves hazardous [γ-32P]ATP 
radiolabeling. Alternatively, custom-made labels are synthetically introduced to the 
 1 2 3 4 5 6 
ATP - - + + - + 
ATP-biotin + + - - + - 
T4PNK - + - + - - 
PNK reaction buffer + + + + - - 
Figure 2.14 – Degradation analysis of ATP-biotin by T4 PNK. The phosphoramidate 
bond in ATP-biotin does not degrade in the presence of T4 PNK and T4 PNK buffer. 
Thin layer chromatography (TLC) analysis showing that ATP-biotin (200 µM) does 
not degrade after a 2 hour incubation at 37°C with T4 PNK (2 units/µL) and kinase 
buffer (lanes 1 and 2).  ATP and ATP-biotin (200 µM) are also shown for comparison 
(lanes 3 and 4).  The TLC solvent system used was isopropanol: ammonia: water 
(3.5: 1.5: 0.5)	
ATP-biotin 
ATP 
T4PNK 
Buffer  
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desired polynucleotide substrates for purification purposes.  As an alternative, a non-
hazardous and robust bench-top kinase-mediated labeling method was proposed in this 
work where a 5’ phosphorylbiotin group was introduced through PNK mediated reaction. 
Similar to protein kinases, crystallographic studies of T4 PNK show a solvent exposed 
ATP binding site, which could facilitate the binding of γ-phosphate modified ATP to the 
enzyme. Based on this analysis, we hypothesize that T4 PNK could also transfer a 
phosphobiotinyl group from ATP-biotin to ss/ dsDNA substrates. 
 A variety of methods were employed to characterize kinase-catalyzed 
biotinylation of ssDNA.  All data confirmed the compatibility of ATP-biotin as a T4 PNK 
cosubstrate.  ADP-Glo™, gel electrophoresis, and MS analyses were consistent with 
labeling by ATP-biotin and T4 PNK. Gel shift analysis showed that the ATP-biotin 
reaction had comparable efficiency to the ATP reaction (67-47% versus 60-40% 
conversions, Figures 2.9 ans 2.10). Dot blot analysis documented the presence of only 
11% biotinylated DNA product after kinase-catalyzed reaction (Figure 2.12), which is 
significantly lower than the 42% conversions observed by gel analysis (Figures 2.9). But 
the combined data show that ATP-biotin is a T4 PNK cosubstrate with conversion 
efficiencies comparable to ATP phosphorylation.  
The experimental results of the ADP-glo assay suggests that ATP-biotin is 
consumed as a cosubstrate by T4 PNK, while MALDI-TOF MS and gel shift results 
showed poor percentage of biotinylation. Dot-blot analysis suggested that the 
phosphoramidate bond cleaves after kinase-catalyzed biotinylation, which releases the 
biotin tag to generate a 5′-phosphorylated DNA product. As an alternative approach, 
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ATP analogs containing phosphodiester or phosphonate bonds are more stable than 
those containing phosphoramidate bonds,104 suggesting that use of an ATP analog with 
biotin attached though a more stable linkage would be successfully used for T4 PNK 
mediated labeling. For an example, phosphorothioate-containing ATP analogs are 
cosubstrates for T4 PNK and produced stable DNA products,86 Alternative ATP analogs 
chould be explored for kinase-catalyzed labeling.  The results of this chapter indicate 
that kinase-catalyzed labeling of T4 PNK require further optimization for high efficiency 
DNA labeling.  Further exploration of the scope and limitations of kinase-catalyzed 
biotinylation, will lead to the development and application of kinase-catalyzed labeling 
as a novel tool in nucleic acid research. 
2.4 Experimental section 
2.4.1 Materials 
The disodium salt of adenosine 5’-triphosphate (ATP-2Na) was obtained from 
Fisher. T4PNK buffer (1x, containing 7 mM Tris–HCl, 0.25 mM MgCl2, and 0.5 mM 
dithiothreitol (DTT) (pH 8.0)), T4 polynucleotide kinase (T4 PNK), and polyethylene 
glycol (PEG, 24% w/v) were obtained from NEB. The 28mer DNA (1 µM, sequence: 5’-
GAC CGT AGG CAA GAG TGT GCT TTT TTT TT-3’) was obtained from Invitrogen. The 
28 mer biotin-tagged DNA (1 µM, sequence: 5′-biotin-GAC CGT AGG CAA GAG TGT 
GCT TTT TTT TT-3’) and the reverse primer used in the PCR amplification (5’-TAT CAT 
GTC TGG ATC CGG-3’) were obtained from Eurofins. Agarose, agarose gel apparatus, 
two inner and two outer 1.5 mm gel plates, two 1.5 mm gel combs, urea gel casting 
stand, gel comb, Tris base, ethylenediaminetetraacetic acid (EDTA), loading dye, 
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sodium chloride, potassium chloride, Tween-20, urea, glycerol, borate, 10% ammonium 
persulfate (APS), and acetonitrile were obtained from Fisher Scientific. Ethidium 
bromide, 20x saline-sodium citrate (SSC) buffer, triethylamine, the 37-mer DNA (5’-
GGG CTG GGG GCG CGC ACC ATG CAA AGA AGT CCG AGG C-3’), and the biotin-
tagged 37-mer used as a positive control (5’-biotin-GGG CTG GGG GCG CGC ACC 
ATG CAA AGA AGT CCG AGG C-3’) were obtained from Sigma Aldrich. The QIAquick 
Gel Extraction Kit (contains QG buffer, PE buffer, and QIAquick spin column) was 
obtained from Qiagen. The ADP-Glo™ assay kit, 1 kb DNA ladder, dNTP mix (10 mM), 
Pfu DNA polymerase buffer (10x, 200mM Tris-HCl (pH 8.8 at 25°C), 100 mM KCl, 100 
mM (NH4)2SO4, 20 mM MgSO4, 1.0% Triton® X-100 and 1 mg/mL nuclease-free BSA) 
were obtained from Promega. Pfu DNA polymerase (2-3 U/µL) was expressed and 
purified in the Pflum lab. Acrylamide:Bis-acrylamide, (37.5:1, 40% Solution) and 
Millipore Immobilon NY+ membrane were obtained from Millipore. SYBR gold nucleic 
acid gel stain and streptavidin-Cy5 stain were obtained from Life Technologies. Agarose 
gel casting apparatus was obtained from Owl. Tetramethylethylenediamine (TEMED) 
was obtained from Acros Organics. 
2.4.2 Instrumentation 
The luminescence values for the ADP-Glo assay were measured with a 
fluorimeter (GENios Plus Tecan). Mass spectrometric analysis was performed using a 
MTP Plate (Bruker) and a MALDI-TOF instrument (Bruker Ultraflex). The polymerase 
chain reaction (PCR) was performed using an Eppendorf Mastercycler. The power 
supply for gel electrophoresis was from BioRad. The membrane and gel imaging was 
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performed with the Amersham Biosciences Typhoon 9210 Variable Mode Imager. For 
HPLC analysis, Waters 1525 binary HPLC pump and Waters 2998-photodiode array 
detector were employed. A reverse phase C-18 column (YMC America, INC 250Å~4.6 
mm, 4μm, 8 nm) was used. Dot blot was performed using Bio-Dot® microfiltration 
apparatus (Bio-Rad).  
2.4.3 ATP-biotin synthesis 
2.4.3.1 Synthesis of biotin-PEG amine (6) 
In a 100 mL round bottom flask, biotin (4) (977 mg, 4 mmol) was dissolved in 
DMF (5 mL). TBTU (1.54 g, 4.8 mmol) and DIPEA (0.836 mL, 4.8 mmol) were added 
and the mixture was stirred at room temperature for 30 min and a white colored 
precipitate was obtained. The precipitate was collected by gravity filtration, dissolved in 
DCM (5 mL) and added drop-wise to a solution of 4,7,10-trioxa-1-13- tridecanediamine 
(7) (2.2 mL, 10 mmol) in DCM (250 mL), at 4 ºC. After addition was complete, the 
reaction mixture was stirred for 8 hrs at room temperature. The reaction progress was 
monitored by TLC (3:1:0.5 EtOH: DCM: NH4OH, Rf =0.60). The solvent was removed in 
vacuo. The product was purified by flash chromatography on silica gel with EtOH/DCM 
(1:1 to 3:1 v/v) to yield 78% of biotin-PEG-amine (6) as brown solid (1.59 g, 89% yield). 
The characterization is same as published.105  
2.4.3.2 Synthesis of ATP-biotin (1) 
Adenosine 5’- triphosphate disodium salt (27.5 mg, 0.05 mmol) was dissolved in 
water (5 mL) and the pH of the solution was raised to 7.0 by adding 1M sodium 
hydroxide. 1-(3-Dimethylaminpropyl)-3-ethylcarbodiimide hydrochloride (EDCI, 383 mg, 
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2 mmol) dissolved in water (1 mL) was added to the reaction mixture. The pH of the 
solution was adjusted to 5.6 with 1 M hydrochloric acid and a pH range between 5.6-5.8 
was maintained throughout the reaction. Biotin-PEG-amine (6) (894 mg, 2 mmol) was 
added to the ATP solution and progress of the reaction was monitored by TLC (6:3:1 
iPrOH: NH4OH: H2O Rf =0.69). The reaction was stirred for 4 hours and then treated 
with triethylamine (TEA) to reach pH 8.0. The product was purified on DEAE Sephadex-
A25 anion exchange column. The column was run with flow rate of 4 mL/min using a 
peristaltic pump. A stepwise elution using 5%, 10%, 25%, 37.5%, 50%, 75% and 100% 
triethylammonium bicarbonate buffer (TEAB) was applied. The product eluted between 
37.5- 50% TEAB. Purified product was lyophilized to obtain ATP-biotin (1) as a white 
TEA salt (17 mg, 37% yield).	1H NMR (400 D2O): δ1.28-1.83 (m, 8H), 2.14 (t, J=7.2 Hz, 
2H), 2.64-2.96 (m, 6H), 3.16-3.19 (m, 1H), 3.38-3.59 (m,14H), 4.12 (m, 2H), 4.28 (m, 
2H), 4.42 (m, 3H), 5.94 (t, 1H), 8.18 (s,1H), 8.21 (s, 1H). MALDI-TOF MS: m/z 
calculated for C30H51N9O17P3S [M-H]- 934.23, observed 934.940.  
2.4.4 Kinase-catalyzed phosphorylation / biotinylation of oligomers and DNA 
Oligomer substrate (14-mer, 28-mer, or 37-mer DNA, 20 µM) in distilled water 
was heated in a boiling water bath for 1 min and then immediately dipped in an ice bath. 
After 2 min of cooling, T4 PNK buffer, ATP or ATP-biotin (200 µM), and T4 PNK enzyme 
(2 units/µL) were added into a 25 µL total volume. The reaction was mixed well by 
pipetting and incubated at 37 oC for 2 hrs (or only 1 hr incubation for the ADP-glo assay) 
without shaking.  Critical controls included reactions where T4 PNK or ATP-biotin was 
omitted and replaced with water.  The reactions were analyzed as described below.   
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2.4.5 ADP-Glo kinase assay for T4 PNK (28mer) 
In a 96-well white plate, T4 PNK (2 units/µL) was mixed with 28-mer DNA (20 
µM) in T4 PNK buffer. The kinase reaction was initiated by adding ATP or ATP-biotin 
(200 µM). Final volumes of the reactions were 25 µL. The reactions were incubated at 
37 oC for 1 hr and then terminated by adding ADP-Glo™ reagent (25 µL) and incubating 
at room temperature for 40 min. Kinase detection reagent (50 µL) was added and the 
reaction was incubated for 30 min at room temperature. Finally, luminescence signal 
was measured using a microplate reader (GENios Plus, Tecan).  The mean 
luminescence signal and standard error from three independent trials is displayed in 
Figure 2.6 and Table A.1. 
2.4.6 MALDI-TOF mass spectrometric analysis of kinase-catalyzed biotinylation of  
oligomer (14mer) 
After T4PNK-catalyzed labeling (section 2.4.4), oligomer products were purified 
by ethanol precipitation as follows. Sodium acetate (75 mM, pH 5.2) and ethanol (75%) 
were added to the kinase reaction and incubated on dry ice for 30 min. Samples were 
centrifuged at 14,000 x g for 30 minutes at 4 oC to collect the DNA pellet. The product 
pellet was dissolved in dH2O (2 µL) and then mixed with a saturated solution of 3-
hydroxypicolinic acid matrix in 1:1 acetonitrile:0.0833 M ammonium citrate in water (2 
µL). The sample (1 µL) was spotted onto a MTP Plate (Bruker) and analyzed using a 
MALDI-TOF instrument (Bruker Ultraflex). Full gel images and repetitive trial are shown 
in Figures 2.7 and A.4.  
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2.4.7 Gel shift analysis of oligomers (28mer and 37mer) 
Oligomer products after T4PNK-catalyzed labeling (section 2.3) were separated 
by 20% denaturing urea polyacrylamide gel electrophoresis in Tris/Borate/EDTA (TBE) 
buffer (1X: 89 mM Tris, pH 7.6, 89 mM boric acid, 2 mM EDTA) and visualized using 
SYBR Gold Nucleic Acid Gel Stain (Life Technologies) according to the manufacturers 
protocol.  Oligomer gel bands from SYBR Gold Nucleic Acid Gel Stain were detected on 
a Typhoon imager (excitation wavelength 495 nm and an emission at 537 nm).  Band 
intensities were quantified using ImageJ software (NIH). Conversion percentages were 
calculated by dividing the intensity of the product band by the intensity of the total DNA 
(unreacted and product bands), and multiplying by 100. Repetitive trials are shown in 
Figures 2.9, 2.10, A.5, A.6, and A.7.  
2.4.8 Southern blot of the DNA (PCR amplified products - 417mer fragment) 
The 37-mer DNA fragment was used as the forward primer (0.5 µM) in a 50 µL 
PCR reaction containing reverse primer (0.5 µM), template DNA (0.5 µM; pBJ5-
HDACI),106 dNTP (200 µM each), DMSO (10 %) and Pfu DNA Polymerase enzyme 
(0.025 units/μL) in Pfu DNA Polymerase buffer (20 mM Tris-HCl (pH 8.8), 10 mM KCl, 
10 mM (NH4)2SO4, 2 mM MgSO4, 0.1 mg/mL nuclease-free BSA, and 0.1% Triton® X-
100). After PCR amplification, the 417-mer product was purified on a 1% agarose gel in 
1X TBE buffer (89 mM Tris, pH 7.6, 89 mM boric acid, 10 mM EDTA). The gel band with 
the correct 417 base pair size was excised and purified by QIAquick Gel Extraction Kit 
spin columns (Qiagen). The concentration of purified DNA was determined using UV/Vis 
spectroscopy Nanodrop 2000.  The purified PCR product was then used in a T4 PNK-
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catalyzed biotinylation reaction (Section 2.4.4). The T4PNK reaction product was 
separated using a 0.7% agarose gel in 0.5X TBE buffer (44.5 mM Tris, pH 7.6, 44.5 mM 
boric acid, 1 mM EDTA). A positive control PCR reaction was also included in the gel 
analysis, which was generated using a synthetic 5’-biotinylated 37-mer (0.5 µM) as the 
forward primer. The gel was soaked in the alkaline transfer buffer (0.4 N NaOH, 1 M 
NaCl) for 45 min, followed by capillary transfer using Immobilon-Ny+ membrane (EMD 
Millipore). After 8 hrs of transfer, the membrane was blocked using blocking buffer (90 
mM sodium citrate, 900 mM NaCl, 0.5% SDS, 100 μg/mL salmon sperm DNA, 1 mM 
EDTA, pH 7.0) for 2 hrs.  The membrane was then stained with SYBR Gold Nucleic 
Acid Gel Stain or a Streptavidin-Cy5 conjugate, according to the manufacturers 
protocols, followed by scanning using a Typhoon scanner (Amersham Biosciences). SA-
Cy5 stained membranes were visualized using an excitation wavelength of 633 nm and 
an emission at 670 nm. Repetitive trials are shown in Figures 2.11 and A.8. 
2.4.9 Dot-blot analysis of kinase catalyzed biotinylation of DNA (PCR amplified  
products - 417mer fragment) 
Crude oligomer products after PCR amplification, gel purification, and T4PNK-
catalyzed labeling (section 2.4.9) were directly transferred onto Immobilon-Ny+ 
membrane (EMD Millipore) using Bio-Dot® microfiltration apparatus (Bio-Rad), 
according to the manufacturers protocol. After transfer, the membrane was washed with 
dH2O, followed by blocking, staining, and scanning as described in section 2.4.9 Spot 
intensities were quantified using ImageJ by drawing the same size circles around 
comparable spots on the SA-Cy5 stained gel. Percentage conversion was calculated by 
dividing the band intensity of the kinase-catalyzed biotinylated product by the band 
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intensity of the PCR product generated using the synthetic 5’-biotinylated DNA, and 
multiplying by 100. Repetitive trials are shown in Figures 2.12 and A.9. 
2.4.10 Denaturing urea polyacrylamide gel electrophoresis 
Denaturing urea polyacrylamide gels were prepared in lab as follows. For the gel 
shift experiments 20% acrylamide gels were used. The denaturing urea gel was 
prepared with Mini-PROTEAN gel plates (BioRad) as described.107 The gel plates (inner 
plate -10.1 x 7.3 x 0.15 cm and Outer plate -10.1 x 8.2 x 0.15 cm) were assembled on 
the gel casting apparatus.  The 20% polyacrylamide solution was prepared by mixing 
1.2 mL of 10X Tris/ Borate/ EDTA (TBE) buffer (1 M Tris, 1 M boric acid, 0.02 M EDTA, 
pH 8.3), 6 mL of 40% v/v 29:1 acrylamide:bisacrylamide, 1 mL dd water, and 5.04 g 
urea to a 50 mL sterile beaker. Polymerization was initiated by the addition of 60 μL of 
10% ammonium persulfate (APS in water), followed by 4 μL of TEMED. The gel was 
immediately poured using a serological pipette between the two glass plates.  The comb 
was inserted and the gel was allowed to polymerize for 30-60 minutes. The gel was 
removed from the casting chamber and assembled to the gel running apparatus. The 
gel running chamber was filled with 1X TBE (0.1 M Tris, 0.1 M boric acid, 0.002 M 
EDTA, pH 8.3) buffer up to the top of the gel plates. The comb was carefully removed 
and the wells were rinsed with the 1X TBE buffer using a pipette and gel loading tips. 
The gel pre-ran for 30 minutes to heat the gel up and to remove remaining urea from the 
gel. The optimal temperature should be between 45-55 °C. The 2x gel loading mix (90% 
formamide, 0.5% EDTA, 0.1% xylene cyanol and 0.1% bromphenol blue) was added to 
the DNA sample and loaded to the pre-run gel. The samples were loaded to the bottom 
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of the wells with long tips and ran the gel was run at a constant 200 V until the 
bromphenol blue marker dyes front reached the lower end of the gel. 
2.4.11 SYBR gold stain visualization 
The gel to be stained was placed on a pipet tip box lid and covered with 1X TBE 
buffer where SYBR Gold stain stock solution was 10,000-fold diluted to make a 1X 
staining solution (50 mL). The staining solution was protected from light by covering the 
container with aluminum foil and incubated in the dark for 20 minutes. The stained gel 
was rinsed once with 1X TBE and imaged using the Typhoon scanner at an excitation 
wavelength of 495 nm and an emission of 537 nm. 
2.7.12 Gel Image Quantification 
Gel bands were quantified using ImageJ software by drawing the same size 
rectangular shape around comparable bands. Profile plots were generated for each 
lane, which represent the relative density of the contents of the rectangle over each 
lane. The percentage of phosphoprylated or biotinylated ssDNA observed after kinase 
reaction was calculated by dividing the intensity of the phosphorylated band by total 
DNA (unreacted and phosphorylated DNA), and multiplying by 100. The percentages 
displayed in Figures 2.9 and 2.10 are average percentages and standard error of 
observed phosphorylated or biotinylated DNA from three independent trials (Figures 
A.5, A.6 and A.7) 
2.7.13 Degradation analysis of ATP-biotin by T4 PNK 
T4 PNK buffer, ATP or ATP-biotin (200 µM), and T4 PNK enzyme (2 units/µL) 
were combined in a 25 µL total volume. The reaction was mixed well by pipetting and 
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incubated at 37 oC for 2 hrs without shaking.  Critical controls included reactions where 
T4 PNK, ATP or ATP-biotin was omitted and replaced with water.  The reactions were 
analyzed by TLC, with mobile phase solvent system isopropanol: ammonia: water (3.5: 
1.5: 0.5) and the products were visualized by anisaldehyde stain. 
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CHAPTER 3 STUDYING THE ATP COSUBSTRATE PROMISCUITY OF LIPID  
KINASES 
 In this chapter, the importance of lipid phosphorylation and its contribution to 
cellular functions are discussed. Experiments were performed to establish kinase-
catalyzed labeling of lipids, where shingosine kinase 1 (SPHK1) was employed with γ-
phosphate-modified ATP analogs to label the sphingosine (Sph) substrate. The 
products were analyzed by TLC, RP-HPLC and mass spectrometry to confirm the 
presence of a phosphoryl modification on Sph. ATP-biotin and ATP-dansyl were 
employed as the γ-phosphate-modified ATP analogs. 
3.1 Introduction 
3.1.1 Introduction to Lipid Kinases  
 Lipids play an important role in the cell signaling of many different physiological 
responses.108,109,110 In addition to being a source of energy storage111 and the building 
block for cell membrane112, lipids are identified as bioactive molecules with functions in 
cell-surface receptor stimulation and second messengers.113,114 Lipid kinases 
phosphorylate many of lipid molecules including phosphatidylinositols (Figure 3.1A), 
phosphatidylcholine derivatives (Figure 3.1B), and sphingolipids (Figure 3.1C), that act 
as lipid-derived second messengers, and diacyl glycerol (Figure 3.1D) which is an 
extracellular ligand.115 Cell signaling mediated by lipids differs from other signaling 
pathways as lipid signaling molecules can freely diffuse through the cell membrane lipid 
bilayer and are not stored in vesicles prior to its use. Instead, they are biosynthesized 
as needed. Phosphorylation of the lipids by their corresponding kinase alters the 
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polarity, leading to changes in cellular distribution.  Therefore, phosphorylationis a key 
regulator of lipid biochemistry.  
 Phosphoinisitide 3-kinases (PI3K) were the first mammalian lipid kinases 
discovered.116 Since then, advances have been made to understand phosphoinisitide 
(PI) mediated lipid signaling. PI derivatives, such as IP3, can activate G protein-coupled 
receptors, tyrosine kinases, phosphatidylinositol (3,4,5), and functions as cytokines and 
ligand surface antigents. PI3K is responsible for physiological responses, such as 
vasoconstriction/ relaxation, cell proliferation, migration and survival.117,118 The next 
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important lipid signaling molecules are sphingolipids. Their biology and function will be 
discussed in detail in the next section, given their emphasis in this chapter.118  
3.1.2 Sphingolipid signaling 
 Sphingolipids consist of a large array of bioactive lipids contributing to membrane 
biology and cell signaling pathways.119 Fascinatingly, the name “sphingo” derives from 
the Greek word “Sphinx” to emphasize the enigmatic nature of sphingolipids.120 Similar 
to other phospholipids, sphingolipids are composed of a polar head group and two 
nonpolar tails. The core of all sphingolipids is the long-chain amino alcohol, sphingosine 
(Figure 3.2 green only). Amino acylation with a long chain fatty acid at carbon 2 of 
sphingosine yields ceramide (Figure 3.2 green and yellow).  
The production and metabolism of sphingolipids takes place via de novo 
synthesis (Figure 3.3).121,122 The de novo synthesis takes place in endoplasmic 
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reticulum where palmitoyl CoA and serine are condensed to form 3-ketosphinganine by 
the catalysis of serine palmitoyl transferase (SPT). Next, the 3-ketosphinganine is 
reduced by a NADH dependant reductase (KDS) to produce sphinganine 
(dihydrosphingosine). Ceramide synthase (CS) catalyzes the addition of different 
lengths of acyl chains (by fatty acyl CoA) to produce dihydroceramide. The product is 
reduced by dihydroceramide desaturase (DES) to form ceramide. Ceramides are 
considered as the central hub for sphingolipid metabolism. Ceramide has several fates. 
Ceramides get phosphorylated by ceramide kinase (CK) to form ceramide-1-phosphate. 
Ceremides also will undergo glycosylation in the golgi apparatus by glucosylceramide 
synthase or galactosylceramide synthase. Ceramides convert to sphingomyelin after 
addition of a phosphorylcholine headgroup by sphingomyelin synthase (SMase). 
Ceramide hydrolyzes to form sphingosine, which undergoes phosphorylation by 
sphingosine kinase (SPHK) to form sphingosine-1-phosphate (S1P). The reverse 
reaction is catalyzed by S1P phosphatase (SPPase) to regenerate sphingosine.  
Out of all the sphingolipids, only sphingosine, ceramide, sphingosine-1-
phosphate and ceramide-1-phosphate are identified as bioactive sphingolipids, where 
the remaining function as structural components.123 The bioactive components are inter-
convertible sphingolipid metabolites. The most fascinating fact about the signaling 
properties of sphingolipid metabolites is that the actions of the unphosphorylated or 
deacylated forms are often opposed to the phosphorylated or acylated forms and 
thereby, the balance of “sphingolipid rheostat” must be strictly regulated.124  Ceramide 
and sphingosine levels increase in response to many stress stimuli and are associated 
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with growth arrest and apoptosis, while S1P has the opposite action, where increasing 
S1P levels suppress apoptosis and increase the cell proliferation.  
3.1.3 The biology of SPHK, Sph and S1P  
S1P has been shown to regulate a variety of cellular processes and the relative 
levels of ceramide and sphingosine compared to S1P plays a critical role in determining 
cell fate.125 S1P is synthesized by phosphorylation of Sph catalyzed by SPHK, which 
plays an essential role in regulating S1P levels.126,127 Two isoforms of SPHK (SPHK1 
and SPHK2) are known and each exhibit different properties and subcellular locations. 
Both kinases phosphorylate the same substrates, which include, erythrosphingosine 
(sphingosine), dihydrosphingosine and phytosphingosine.125 SPHK1 is located on 
chromosome 17 and SPHK2 is located on chromosome 19 in humans.126 SPHK1 is 
abundantly expressed in heart, spleen, lung, and brain of an adult mouse, while SPHK2 
expression is expressed highest in brain, kidney, and liver.127 When considering the 
cellular localization, SPHK1 is abundant in the cytosol of most cell types and better 
studied than SPHK2 as localization of SPHK2 is cell type specific. Higher expression of 
SPHK1 is associated with cell survival and proliferation in many types of cancer (breast, 
colon, lung, ovary, stomach, uterus, kidney, and rectum).128 Hence, SPHK1 represents 
a promising novel molecular target for therapeutic intervention in cancer and 
inflammatory diseases. The biological function of SPHK2 is not clearly identified. Unlike 
SPHK1, SPHK2 leads to cell apoptosis by localizing in the nuclei and causing inhibition 
of DNA synthesis.129 
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, There are many different extracellular stimuli that trigger the activity of SPHK1, 
including various growth factors such as platelet-derived growth factor (PDGF)130, 
epidermal growth factor (EGF)131, vascular endothelial growth factor (VEGF)132, nerve 
growth factor (NGF), basic fibroblast growth factor (bFGF), transforming growth factor 
beta (TGFβ), and insulin-like growth factor-1 (IGF-1). Also cytokines such as TNF-α and 
interleukins,133 and hormones (estradiol and prolactin)126,134 also regulates the activity of 
Figure 3.3 – Sphingolipid metabolism pathway where bioactive lipids are highlighted 
in blue. More details are provided in the text. 
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SPHK1. SPHK1 is primarily cytoplasmic, but translocates to the plasma membrane in 
response to above-mentioned stimuli, where it can produce S1P. The S1P acts 
extracellularly to promote survival, proliferation and migration.135 The main source of 
extracellular serum S1P are platelets136 and vascular endothelial cells137, and S1P is 
found in human serum at an average concentration of 0.5μM.138 SPHK2, in contrast, is 
primarily found in the endoplasmic reticulum and stimulates apoptosis independent of 
extracellular mechanisms.135  
 S1P can act extracellularly as a ligand for G-Protein coupled receptors coded by 
endothelial differentiation genes and are known as S1P receptors (S1P1, S1P2, S1P3, 
S1P4, S1P5).139,140 S1P receptors are differentially expressed and coupled to a variety of 
G proteins.141 Thereby, S1P mediates diverse biological processes. Each of these, Gi, 
Gq, and G12/13, activate various down-stream signaling pathways. For an example, Gi 
activation is associated with Ras/ERK pathway,142,143 phospholipase C,144 and 
Akt/Pi3K,145 all of which contribute to cellular proliferation. Thus confirming that S1P 
plays an important role in modulating a wide range of cellular processes, including 
proliferation, angiogenesis,132 stimulation of adherent junctions,146 enhanced 
extracellular matrix assembly, formation of actin stress fibers, and inhibition of apoptosis 
induced by ceramide or growth factor withdrawal.147 Also, activation of SPHK1 by 
various agonists increases intracellular S1P, which will be secreted out of the cell and 
act extracellularly by binding to and signaling through S1P receptors in an autocrine 
and/or paracrine manner through “inside-out” mechanism.148 Although S1P can rapidly 
move throughout the cytosol from its site of synthesis, there is evidence that localizing 
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SPHK to specific sites can promote the association of S1P with specific intracellular 
effectors. Inside cells, only three S1P interacting proteins have been reported. For 
example, the nuclear localization of SPHK2 and its effect on histone deacetylases 
HDAC-1 and HDAC2 have recently shown that S1P is an inhibitor of these histone 
deacetylases and only SPHK2-based S1P is responsible for the inhibitory action.149 S1P 
is an effector of Traf2, which is a component of the TNF receptor-signaling complex. 
S1P is a required co-factor to stimulate Traf2’s activity as an ubiquitin ligase, and 
specific targeting of SPHK1 to the TNF receptor complex promotes the binding of S1P 
to Traf2.150 Additionally, S1P produced in the mitochondria mainly by SPHK2 binds with 
high affinity and specificity to prohibitin 2 (PHB2), a highly conserved protein that 
regulates mitochondrial assembly and function.151 As this short discussion highlights, 
S1P is playing an important role in cell biology of many biological processes. 
3.1.4 Methods and analytical tools to study sphingolipids 
Although lipid-signaling plays an important role in cell biology research, our 
understanding of sphingolipid signaling has lagged far behind the studies of proteins 
and nucleic acid biology. This slow progress is mainly due to the lack of simple and 
straightforward assays for lipid studies (for example, techniques similar to gel analysis 
for proteins and quantitative PCR approach for nucleic acids).  
Classic approaches for sphingolipids analysis often require multiple steps, 
including thin layer chromatography (TLC) pre-separation, enzymatic deacylation, and 
HPLC analysis after derivatization (fluorophore or radiolabeling by [γ-32P]ATP). These 
methods are time-consuming and lack specificity and sensitivity. The ability to make 
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accurate and sensitive measurements of lipid levels was attained with the use of liquid 
chromatography, coupled with tandem mass spectrometry (LC–MS/MS),152 which is a 
powerful tool to address the analytical challenge raised by the complexity and diversity 
of sphingolipidome. However, this approach is unable to study at the sub-cellular level. 
Derivatized lipid analogs containing biotin, a fluorophore, or a solid phase on the lipid 
terminus have been used to assess binding partners and SPHK activity (developed by 
Echelon, Inc and Invitrogen). However, due to the transient nature of the binding with 
the associated proteins, only very few interactions were identified using these lipid 
analogs.151 
 Chemical approaches to probe lipid function, localization, or ligand binding are in 
high demand and will revolutionize the lipidomics studies. In this work, a chemical tool is 
proposed to study lipids based on kinase-catalyzed labeling. Herein, the compatibility of 
γ-phosphate modified ATP (ATP-biotin and ATP-dansyl) as a cosubstrate for SPHK1 is 
studied (Figure 3.4), where kinase-catalyzed labeling can be employed for Sph 
substrate as a proof of concept. This initial step would provide a new approach for 
chemical labeling of lipids in biological systems. 
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3.1.5 Crystallographic analysis of Lipid Kinases 
 The crystal structure of various lipid kinases was studied to provide rationale that 
lipid kinases would accept γ-phosphate modified ATP analogs as their cosubstrates. 
Herein, the crystal structures of phosphatidylinositol-3 kinase (PI3K) was analyzed to 
explore whether ATP binding pocket would exhibit the solvent exposure, similar to 
protein kinases (as described in Chapter 1). 
  
Phosphoinositide 3-kinases (PI3K) phosphorylate 3-hydroxyl groups of 
phosphoinositides (Figure 3.1A). Based on the substrate specificity and the structure, 
PI3Ks are divided into three different classes.153 The structures show a multi-domain 
organization with the catalytic domain of PI3K having a similar fold to that of the protein 
kinases.6 The catalytic domain has two lobes where a smaller N-terminal lobe and a 
A. B. 
Figure 3.5 – A) The active site of PI3K showing the ATP analog (AMPPNP in blue) 
and substrate (Ins(1,4,5)P3 in red)  bound to the enzyme. Side chains interacting with 
the ligands are shown as sticks and ligand-bound water molecules as white spheres5 
B) PI3K (green) in complex with ATP (red) (PDB 1E8X). The γ-phosphate of ATP is 
pointing towards the reader6 
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larger, primarily helical C-terminal lobe. The ATP cosubstrate binds between these 
lobes (figure 3.5A), similar to ATP binding in protein kinases154, where the ATP and 
metal co-factor binds to residues in the linker between N and C lobes.  
According to the crystal structure, the adenine moiety of ATP hydrogen bonded 
to the main chain of residues Gln249 and Leu251 in the ATP-binding cleft (Figure 3.5A) 
and the hydrophobic pocket for the adenine and ribose is formed by residues from the 
both C and N lobes. The strictly conserved Asp416 among PI3Ks coordinates the α and 
γ phosphates via the Mn2+ co-factor. This aspartate seems to position the γ phosphate 
for subsequent nucleophilic attack by the 3-OH of the substrate, which is within a 3.7 Å 
distance. The complex with ATP shows a similar solvent exposed γ-phosphate as the 
protein kinases, which exhibit cosubstrate promiscuity with γ-phosphate modified ATP 
analogs (Figure 3.5B).  
As other lipid kinases possess similarity in sequence to PI3K, they would also 
possess solvent exposed ATP binding pocket. In this work, cosubstrate promiscuity of 
SPHK1 was studied for the proof of concept, because it is commercially available 
(Cayman) and is the interest of our collaborator Menq-jer Lee in the Bioactive Lipids 
Research Program at Wayne State University. Althought the crystal structure is not 
available for SPHK1, it is reported that the domain architecture shows resemblance to 
diacylglycerol kinases (DGK), which is a member of PFK-like superfamily.155 The 
crystallographic analysis ATP bound complex of DGK (Figure 3.6 A) shows that the 
terminal phosphate of ATP is solvent exposed. However, the homology model proposed 
by Hurlbert lab (Figure 3.6B), suggests that ATP would bind to the active domain in a 
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solvent exposed manner and can facilitate the binding of modified ATP analogs to 
successfully transfer the modified γ-phosphate to the Sph substrate.	 
 
 
 
 
3.2 Results 
3.2.1 Kinase catalyzed phosphobiotinylation of Sphingosine (Sph) 
The synthesized ATP-biotin (1) (Chapter 2, Section 2.2.1), was used for the initial 
in vitro studies of kinase-catalyzed biotinylation with Sph and SPHK1. The products 
were analyzed by ADP-Glo kinase assay, TLC, HPLC, and mass spectrometric (MALDI-
TOF and MAIV) analysis to confirm the phosphorylbiotinyl modification. 
 
Figure 3.6 – A) DGK1 (green) in complex with ADP (red) (PDB 2QV7)2 where the γ 
phosphate is in the solvent exposed region of the ATP binding domain. B) Homology 
model for human SPHK1 with the putative ATP and Sph binding sites. 
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3.2.1.1 ADP-Glo™ kinase assay analysis of SPHK1 catalyzed biotinylation 
The tolerance of SPHK1 with ATP-biotin was tested with Sph using the ADP-Glo 
assay, as described for T4 PNK (Chapter 2, Section 2.2.2.1). Similar to T4 PNK 
experiments, control experiments were performed to quantify the background 
luminescence obtained in the absence of substrate (Figure 3.7, column 7 for ATP and 
column 8 for ATP-biotin, Table B.1). The background for ATP-biotin reaction was 4-fold 
greater than the ATP control (Figure 3.7, columns 7 vs. 8, Table B.1). This may be due 
to the presence of ADP as an impurity in the synthesized ATP-biotin batch (0.8% ADP 
as an impurity by HPLC quantification Figure A.3). Reactions containing Sph, SPHK1, 
and ATP-biotin produced a 2-fold increase in ADP production compared to reactions 
containing no Sph (Figure 3.7, columns 6 vs. 8). But the efficiency of this reaction was 
lower than the ATP reaction, which showed a 10-fold increase vs. reaction containing no 
Sph (Figure 3.7, columns 5 vs. 7). However, the preliminary ADP-Glo assay analysis 
suggests that SPHK1 accepts ATP-biotin as a cosubstrate, but with less efficiency 
compared to natural ATP. 
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3.2.1.2 Thin layer chromatography (TLC) analysis of kinase-catalyzed  
biotinylation by SPHK1 
3.2.1.2.1 Theory behind TLC separation of lipids 
 TLC is one of the classic approaches used to separate and analyze many 
different classes of lipids, such as cholesterols, triglycerides, shingolipids, free fatty 
acids, diacylglycerols etc.156,157 Due to the simplicity, low cost, and rapid separation, 
TLC is usually the preliminary step in identifying the lipid components of an unknown 
 1 2 3 4 5 6 7 8 
Sph + + + + + + - - 
ATP - - + - + - + - 
ATP-biotin - - - + - + - + 
SPHK1 - + - - + + + + 
Figure 3.7 – ADP-Glo assay results with sphingosine (Sph), SPHK1, and either 
ATP or ATP-biotin, showing arbitrary luminescence units after a 30 min reaction. 
The components corresponding to each reaction are indicated below. The mean 
and standard error of 3 independent trials is shown, with raw data in Table B.1 
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animal or plant tissue sample.158 Resolution of complex lipid mixtures can be obtained 
by changing the solvent combination of the mobile phase. Different stainings can be 
used to visualize the specific functional groups (unsaturated bonds, phosphate, amino, 
sugar etc.) of lipids.156 Better resolution is obtained by performing 2D TLC separation. 
Usually, before TLC separation, lipids are extracted by organic solvents from the other 
biological counterparts and the chloroform/ methanol combination is commonly used to 
extract sphingolipids.159 One of the major drawbacks of using TLC for lipid separation is 
that the lipids may undergo degradation upon long-term exposure to atmospheric 
oxygen. The other major disadvantages are the need of side-by-side standards for the 
identification of the lipid, inability to determine the structure of the separated species, 
and limitation of small-scale separation. 
 Most commonly, silica based stationary phase on a glass-back or Aluminum-
back plate is used for lipid separation. Both normal and reverse-phased silica are used 
depending on the lipid class that has to be separated. It is reported that for the 
separation of more sophisticated lipid mixtures, modified stationary phases are used. 
AgNO3 is one of the common additives to separate lipids based on their degree of 
unsaturation. Ag+ forms complexes with unsaturated bonds, leading to changes in 
migration of the lipid components.160 Additionally boric acid is used when the lipids have 
vicinal –OH groups.161 EDTA is used to get better resolution of acidic phospholipids.162  
 In selecting the mobile phase, the optimum resolution can be achieved by 
changing the solvent strength, which is equivalent to the polarity of the mobile phase. 
Better separation is obtained if the solvent strength is reduced, but the lipid components 
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tend to migrate slowly, leading to low Rf values. In the separation of sphingolipids by RP 
silica, with respective to the rising solvent front, less polar components will migrate 
further while more polar or ionic derivatives migrate slower.163  
3.2.1.2.2 TLC separation of phosphorylated/ biotinylated Sph 
   
En
try
 
 
Mobile phase 
composition 
 
Application 
Rf of the components of 
kinase catalyzed labeling 
of Sph 
1 2 3 4 5 6 
1 Chloroform: 
MeOH: water 
(65:25:4) 
Separates phospholipids 
by polarity 0.
45
 
0.
14
 
0.
14
 
0.
00
 
0.
00
 
0.
50
 
2 Chloroform: 
MeOH: NH4OH 
(65:25:4) 
Separates phospholipids 
by the overall charge of the 
head group 0.
75
 
0.
00
 
0.
00
 
0.
00
 
0.
00
 
- 
3 Chloroform: 
MeOH: Acetic 
acid (65:25:4) 
Separates complexed 
shingolipids such as  
0.
52
 
0.
00
 
0.
00
 
0.
00
 
0.
00
 
- 
4 Toluene:Pyridine:
Water (6:6:1) 
Separates phospholipids 
0.
00
 
0.
00
 
0.
00
 
0.
00
 
0.
00
 
- 
5 Cyclohexane: 
Ethyl Acetate 
(3:2) 
Separates neutral lipids 
0.
00
 
0.
00
 
0.
00
 
0.
00
 
0.
00
 
- 
6 Toluene: 
Chloroform:MeOH 
(17:3:1) 
Separates sphingolipids 
0.
00
 
0.
00
 
0.
00
 
0.
00
 
0.
00
 
- 
Table 3.1 – Reported solvent systems for TLC separation of lipids and observed Rf 
values for the separation of kinase-catalyzed reactions with ATP and ATP-biotin. 
(The Rf values indicated are 1- Sph, 2-S1P, 3- S1P or S1P-biotin product, 4-ATP, 5-
ATP-biotin, 6-SPHK1) 
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In this work, phosphorylation / biotinylation of Sph was analyzed by TLC using 
RP silica and different solvent systems, which were reported in literature. Anisaldehyde 
(for amines)164 and Molybdenum blue (for phosphates)164-165 stains were used for 
visualization of the products. Mixtures of chloroform–methanol–water are regularly used 
to separate sphingolipids based on the head group polarity and the charge. Herein, the 
more polar and charged compounds (S1P) tend to remain closer to the point of origin 
while less polar components will migrate further towards the solvent front. Among many 
of the solvent systems, chloroform: MeOH: water (65:25:4), chloroform: MeOH: NH3 
(65:25:4) and chloroform: MeOH: acetic acid (65:25:4) are specific for the separation of 
sphingolipids and were employed in this study.166,167 After 30 mins of SPHK1-catalyzed 
labeling of Sph with ATP-biotin, the reactions were spotted on the TLC plate alongside 
with the ATP control reaction and unreacted Sph. Once the spots were dried, the TLC 
was developed with the corresponding mobile phase and air-dried prior to visualization 
by molybdenum blue stain (phospholipids will turn blue) and Anisaldehyde (for free 
amines to identify all components of the reaction mixture).  For all three above-
mentioned solvent systems, the less polar Sph migrated faster (Table 3.1, Rf = 0.45, 
0.75, 0.52 respectively), while the remaining components of the kinase reaction 
remained at the origin of the developed TLC plate (Table 3.1). The spots retained at the 
origin turned blue upon staining for both ATP and ATP-biotin reactions, indicating the 
presence of phosphoryl-containing components. The crude reactions consist of 
unreacted ATP, ATP-biotin, and degraded products of ATP, in addition to phosphoryl 
modified Sph. Thereby, under these combinations of mobile phase, no separation of 
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phosphorylated/biotinylated Sph product was achieved from the remaining phosphoryl 
containing components of the reaction mixture. In addition to the above combinations, 
other reported mobile phases for lipids168,169 were also employed in separating the 
phosphorylated/ biotinylated Sph products by TLC, but none of them were successful in 
separating the components of the reaction mixture or the biotinylalted products (Table 
3.1). 	
Pitman and co-workers reported a TLC-based approach to study SPHK1/2 
isoform activities.170 Herein, a optimized mobile phase with a composition of 1-
butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) was used to separate Sph from S1P. 
The more polar S1P was slower migrating than Sph. The reported Rf value for S1P was 
0.7.  After 30 min kinase reaction, ATP and ATP-biotin reactions were compared by TLC 
analysis under this mobile phase condition and visualized by anisaldehyde, ninhydrin 
and molybdenum blue stains. The Rf values for Sph, S1P, SPHK1 and ATP/ATP-biotin 
were 0.81, 0.60, 0.70 and 0.00 respectively (Figure 3.8). The average Rf value was 
determined by 3 trials and as Rf value is a relative value, the migration of component 
was changed depending on the room temperature, humidity, and other environmental 
parameters. After a 30 min kinase reaction, the S1P product from ATP reaction was 
observed by TLC separation (Figure 3.8, lanes 3). A poor conversion to the 
phosphryl/biotinyl-modified product was obtained for the ATP-biotin reaction (Figure 3.8, 
lanes 2). 
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To optimize the reaction conditions, the incubation time was increased and the 
products were TLC analyzed after 1 hr, 1.5 hr, 2 hr, 2.5 hr, and 3 hrs reactions (Figure 
3.9). Similar to the 30 min study, the crude reactions with longer incubation times were 
spotted on TLC, dried, separated by 1-butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) 
mobile phase and visualized by anisaldehyde stain. Here, the ATP and ATP-biotin 
reactions were compared against pure Sph. Compared to the 30 min reaction, the 
intensity of the new product spot at Rf ~0.6 increased with the longer incubation time 
with ATP-biotin (Figure 3.9, lanes 2). The slow reaction of ATP-biotin indicate that 
modification on γ-phosphate with electronically different and large atoms effects binding 
and catalytic mechanism. Thereby, increase in new product formation is expected with 
greater incubation time.  Incubation time greater than 1 hr time would provide better 
4 1 2 3 5 4 1 2 3 5 1 2 3 4 5 
çSolvent front 
çSph 
çS1P 
çOrigin (ATP/ATP-
biotin ATP) 	
Molybdenum 
blue	 Anisaldehyde	 Ninhydrin	
Figure 3.8 – TLC analysis of SPHK1-catalyzed phosphorylation/ biotinylation, after a 30 
min reaction. Butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) mobile phase and 
anisaldehyde, ninhydrin and molybdenum blue stains were used to visualize. Sph (lane 
1), ATP-biotin reaction (lane 2), ATP reaction (lane 3), ATP (lane 4), ATP-biotin (lane 5). 
Second trial is in Figure B.1.  
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conversion for the new Sph product; hence future TLC studies were carried out after 1 
hr incubation of the kinase-catalyzed reaction. There was no significant increase in the 
intensity of the product formed with the incubation times greater than 1 hr. As the 
tendency for ATP-biotin getting degraded to ATP and biotin amine will get higher with 
longer incubation time, the byproduct ATP will compete with ATP-biotin, leading to S1P 
as the product instead of S1P-biotin. Thereby, the incubation was limited to 1 hr in 
future experiments.  
  
 
 
 
 
 
  
  
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 
çSolvent 
 front 	
çSph 
çS1P/ S1P-
biotin 	
çOrigin 
(ATP/ATP-
biotin ATP) 	
30 min	 1 hr	 1.5 hr	 2 hr	 2.5 hr	 3 hr	
Figure 3.9 – TLC analysis of SPHK1 catalyzed phosphorylation/ biotinylation, for 30 
min, 1 hr, 1.5 hr, 2 hr, 2.5 hr and 3 hr reactions. 1-butanol:ethanol:glacial acetic 
acid:H2O (8:2:1:2) mobile phase and anisaldehyde stains were used to visualize.1- 
ATP-biotin reaction, 2- ATP reaction, 3- Sph.  
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3.2.1.2.3 Technical challenges in performing TLC analysis of kinase catalyzed  
labeling of Sph with ATP-biotin 
Several general challenges were constantly experienced with TLC analysis of 
labeled Sph.  
1. The quantification of product formation calculation of % conversion could not be 
performed similar to gel experiment by ImageJ software. This was because a uniform 
staining of the TLC plate could not achieved by anisaldehyde. Also background 
correction couldn’t be performed when S1P modified products were overlapping with the 
SPHK1 TLC spot (see note in Figure 3.9). Moreover, the difference of the size of TLC 
spots caused a problem in selecting uniform area when calculating the percentage 
conversions. To overcome the difficulty of SPHK1 interference, lipids were purified form 
the remaining components of the kinase reaction by chloroform-methanol extraction. 
Once the sphingosine components were extracted to the chloroform layer, the products 
were spotted on TLC and separated by 1-butanol:ethanol:glacial acetic acid:H2O 
(8:2:1:2) mobile phase (TLC images for chloroform extracted Sph are shown in following 
sections). 
2. The biotinyl-modified Sph cannot be distinguished from S1P because the new product 
spots formed by ATP and ATP-biotin reactions have the same Rf ~0.6. The most 
commonly used method to identify biotin modifications on a substrate is to use a 
streptavidin conjugate with a fluorophore. But for TLC staining, streptavidin conjugates 
cannot be used as it binds to the entire TLC plate and washing will not remove the 
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 nonspecifically bound conjugate, leading to a background signal masking the 
biotinylated spots on the TLC. To address this challenge, fluorophore-modified ATP-
analogs were employed (ATP-benzophenone and ATP-dansyl). If the products are 
fluorophore-modified, TLC spots can be directly visualized upon UV lamp rather than 
using a stain. The experiments are discussed in section 3.2.2. 
3. The acidic TLC mobile phase, 1-butanol:ethanol:glacial acetic acid:H2O (8:2:1:2), 
might hydrolyze the phosphoramidate bond of ATP-biotin. The pH value of the mobile 
phase is 3.5 and it is reported that, P-N linked γ-phosphate modified ATP analogs tend 
to hydrolyze to at a pH below 5.5 (Figure 3.10).171 There by, during the TLC separation, 
there is a tendency for the hydrolysis of S1P-biotinyl product to S1P and biotin amine, 
giving the same Rf value as the S1P product of ATP reaction. To address this challenge, 
oxygen and carbon linked ATP analogs, which should not get hydrolyzed in the pH 
range of 2.0- 12.0171 were synthesized and compared with nitrogen linked ATP-biotin 
(discussed in section 3.2.3).  
  
Figure 3.10 – Hydrolysis of S1P-biotin during TLC separation by the acidic mobile 
phase will result in ATP and biotin amine as the products 
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3.2.2 Kinase-catalyzed fluorophore labeling of Sphingosine (Sph) 
 The phosphorylbiotin modification on Sph does not contain aromatic or extended 
conjugation to facilitate visualization under UV light. Thereby, ATP-benzophenone 
(ATP-BP, Figure 3.11) synthesized by Dr. Satish Garre,172 was used as the cosubstrate 
instead of ATP-biotin. The products were separated by TLC after the kinase-catalyzed 
reaction, followed by visualization under UV light.  ATP-BP has been employed as a 
cosubstrate for phosphorylation dependent kinase-substrate crosslinking, where 
simultaneous kinase catalyzed phosphoryl modification and photo-crosslinking would 
take place upon irradiation with UV light to identify kinase-substrate pairs. But herein, no 
UV irradiation was performed during lipid labeling and the sole purpose was to introduce 
the aromatic phosphoryl modification that can be visualized on TLC plate by UV light.  
 Kinase-catalyzed labeling was performed according to the same procedure as 
ATP-biotin and the crude reactions were compared to ATP and ATP-biotin reactions. 
The crude reactions were spotted on the TLC and analyzed using 1-
butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) mobile phase. After TLC separation, 
the dried TLC plate was observed under 234 nm (short wave length light) but no UV 
active spot was observed corresponding to modified Sph product (Figure 3.12). With 
P
O
O
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N
NN
N
NH2
O
OHOH
OPO
O-
O
P
O
O-
NH
O
O NH
2
O
Figure 3.11 – Structure of ATP-BP 
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anisaldehyde stain, ATP and ATP-biotin reactions gave a new product spot at Rf ~ 0.6, 
while ATP-BP reaction gave no trace of new product spot on the TLC lane (Figure 3.12, 
lane 1). The only UV active spots visible after TLC separation were the ATP and ATP 
analog starting materials, which indicate that ATP-BP may not accepted as a substrate 
for the kinase-catalyzed phosphoryl modification of Sph. As ATP-BP is specialized 
cosubstrate for kinase-substrate crosslinking, the phosphoryl modification may not be 
ideal for the visualization under UV, although it contains an aromatic group. Therefore, 
as an alternative, an ATP analog with a fluorophore on the γ –phosphate of ATP would 
be a better alternative for UV visualization of kinase catalyzed labeling of Sph.  
 
 
 
 
 
  1 2 3 4 
1 2 3 4 
çSolvent front 	
çSph 
çS1P/ S1P biotin 	
çOrigin (ATP/ATP-biotin 
ATP-BP) 	
Figure 3.12 – TLC analysis of SPHK1 catalyzed phosphorylation/ biotinylation/ 
benzphonolyzation of Sph after 1 hr incubation at 30 oC. A 1-butanol:ethanol:glacial 
acetic acid:H2O (8:2:1:2) mobile phase and anisaldehyde stain were used to visualize.1- 
ATP-BP reaction, 2- ATP-biotin reaction, 3- ATP reaction, 4- Sph.  
 
		
78 
3.2.2.1 Synthesis of ATP-dansyl analog (2) 
Our previous work successfully employed commercially available ATP-dansyl as 
a kinase cosubstrate for labeling protein and peptide substrates.56 To study the 
compatibility of ATP-dansyl with SPHK1, in this work, the fluorophore-modified ATP 
analog was synthesized and kinase-catalyzed labeling reaction was performed.  
The ATP-dansyl (2) analog was synthesized in two steps, similar to ATP-biotin 
synthesis from Chapter 2. First, dansyl chloride (7) was reacted with the PEG diamine 
linker (5) to yield dansyl-amine (8). The intermediate (8) was purified by silica flash 
chromatography and coupled with ATP according to the reported procedure of ATP-
biotin synthesis. The coupling reaction was performed for 2 hrs in aqueous medium with 
a controlled pH 5.6- 5.8 using EDCI.  
 
 
Scheme 3.1 – Synthesis of ATP-dansyl (2) 
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The purification of ATP-dansyl (2) was attempted with ion exchange column 
chromatography.  The pH of the reaction was raised up to pH 8.5 before purifying the on 
a DEAE sephadex-A25 anion exchange column with the gradient elution of 
triethylammonium bicarbonate buffer (pH 8.5). During the gradient elution with the 
buffer, compound (2) co-eluted with the starting materials using 5% - 100% 1 M TEAB 
and no separation was obtained. Therefore, a TLC separation was performed, as 
reported by Dr. Keith Green in separating the dansyl-modified ATP analog synthesized 
in his project. The crude product of (2) was spotted on a preparative TLC and separated 
with 7:2:1 iPrOH/H2O/NH4OH as the mobile phase. The compound was extracted with 
water and evaporated, but the presence of compound (2) could not be confirmed by 
MALDI-TOF mass spectrometry. Next RP-HPLC (0.1 mM TEAA pH 7.0  / Acetonitrile) 
was employed to separate the product. The filtered product was separated by semi-prep 
C18 RP-HPLC column and the absorbance wavelength 315 nm was selected to identify 
the peaks of the dansylated ATP in TEAA buffer.173 The collected fractions were 
lyophilized and the product purity was checked by TLC and HPLC.  Although MALDI-
TOF confirmed the presence of ATP-dansyl (Figure B.4), TLC and HPLC analysis 
showed trace amounts of ADP and dansyl amine present as impurities. However, as the 
compound ATP-dansyl (2) was present with ATP/ADP impurity less than 5%, the 
kinase-catalyzed labeling experiments were performed with SPHK1.  
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3.2.2.2 SPHK1 catalyzed labeling of Sph with ATP-dansyl cosubstrate 
  Similar to ATP-biotin reactions described in section 3.2.1.2.2, kinase-catalyzed 
dansylation of Sph was performed by incubationg SPHK1 and ATP-dansyl cosubstrate 
for 1 hr at 30 oC. TLC analysis of the dansylation reaction was compared with the ATP 
reaction and unreacted Sph. After reaction, ATP and ATP-dansyl crude reactions were 
spotted on the TLC (Figure 3.13, lanes 4 and 3 respectively). Also, chloroform extracted 
ATP reaction and ATP-dansyl reactions were also spotted next to the crude reaction in 
order to get rid of the remaining reaction components from the lipids (Figure 3.13, lane 1 
and 2). Once the spots were dried, the components were separated by 1-
butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) mobile phase and the dried plate was 
visualized under UV light and anisaldehyde stain. 
  
 
 
1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 
çSolvent front 	
Sphè 
çOrigin (ATP/ ATP-
dansyl) 	
çATP-dansyl 
(degraded) 	
çdansyl amine 	
S1Pè 	
Anisaldehyde 	 UV short  (254 nm) 	 UV long (365 nm) 	
Figure 3.13 – TLC analysis of SPHK1 catalyzed phosphorylation/ dansylation of Sph 
after 1 hr incubation at 30 oC.  A 1-butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) 
mobile phase was  used for separation. Anisaldehyde stain and UV light (254 nm and 
365 nm) were used to visualize the components. Lanes1,3 - ATP-dansyl  reaction, 
Lanes 2, 4- ATP reaction, 5- ATP-dansyl, 6- Sph. The reactions on lanes 1 and 2 
were chloroform extracted before spotting on the TLC plate. A repetitive trial is shown 
in Figure B.3 
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When the products separated by TLC were visualized by anisaldehyde stain (to 
monitor Sph derived products), both crude ATP and ATP crude reactions (Figure 3.13, 
lanes 3 and 4, respectively) showed new product formation, with Rf ~ 0.6 corresponding 
to S1P. When the reactions were chloroform extracted to remove SPHK1 and other non-
lipid components, and calculated percentage conversions for ATP and ATP-dansyl 
reactions were 47% and 12%, respectively. However, when visualized by UV light, no 
UV active product migrating with Sph was observed. Instead, UV active spots were 
observed for ATP-dansyl crude reaction (Figure 3.12, lane 3) with Rf values 0.55 and 
0.65, which were not overlapping with Sph products observed upon anisaldehyde 
staining (Rf ~ 0.6). The same two UV active spots were observed when pure ATP-
dansyl was separated without any reaction components (Figure 3.12, lane 5). With 
reference to the pure ATP-dansyl lane, the UV active products in the ATP-dansyl 
reaction suggest that Sph has not been dansyl-modified by SPHK1. Instead the UV 
active spots may be due to the degradation of ATP-dansyl to dansyl amine and dansyl 
acid by the acidic TLC conditions. There are two hypotheses for the SPHK1-catalyzed 
ATP-danyl reaction. One is that the kinase-catalyzed dansylation reaction might have 
taken place, but due to the acidic TLC conditions, the dansyl-modfied Sph may have 
hydrolyzed to S1P and dansyl amine (as described in Figure 3.10 for ATP-biotin 
reaction). Alternatively ATP impurity present in ATP-dansyl may have caused the S1P 
product, with no SPHK1 catalyzed dansylation reaction. Due to the instability of 
phosphoramidate-linked ATP analogs in the acidic TLC conditions, more stable analogs 
were explored for SPHK1 catalyzed labeling. 
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3.2.3 SPHK1 catalyzed labeling of Sph with oxygen and carbon-linked ATP  
analogs 
3.2.3.1 Kinase-catalyzed labeling of Sph with ATP-O-biotin 
 To study SPHK1-catalyzed labeling with an acid-stable ATP analog, oxygen-
linked ATP biotin (Figure 3.14, ATP-O-biotin 1B), synthesized by Ahmed Fouda from 
our lab, was employed as the cosubstrate. The reaction was performed under the 
optimized condition established with ATP-biotin 1 and product separation was carried 
out by TLC with the mobile phase, 1-butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) as 
dscussed in previous sections of this chapter. Using acid stable oxygen-linked ATP-
biotin, it is expected that the phosphobiotinyl modified Sph will not hydrolyze under 
acidic TLC conditions to S1P and biotin-alcohol (Figure 3.14). Instead, S1P-O-
phosphobiotinyl product will remain stable under the TLC separation and an Rf value 
different form S1P will be exhibited due to the introduction of biotinyl modification to Sph 
 
Figure 3.14 – Kinase-catalyzed biotinylation of Sph with ATP-O-biotin 1B. 
Upon TLC separation, the biotinyl modification will not get hydrolyzed as the 
phosphoramidate linked modification by ATP-biotin 1 
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 After 1 hr incubation of the kinase-catalyzed labeling of Sph, all ATP, ATP-biotin 
and ATP-O-biotin reactions formed a new product with a Rf ~ 0.55, which was as same 
as S1P. The percentage conversions calculated by ImageJ software for ATP, ATP-biotin 
and ATP-O-biotin reactions were 42%, 24% and 11% with respect to starting Sph. 
Although it was expected to observe a new product with a different Rf value than S1P, 
the phosphorylbiotinlyated product had the same Rf value as S1P. The results suggest 
that ATP-O-biotin is accepted as a cosubstrate by SPHK1. But, the labeling with pH 3.5 
 1 2 3 4 5 6 7 
Sph + + + + + + + 
ATP - + - - + - - 
ATP-biotin - - + - - + - 
ATP-O-biotin - - - + - - + 
SPHK1 - - - - + + + 
% Conversions - - - - 42 24 11 
çSolvent front 	
çOrigin (ATP/ ATP-     
biotin analogs) 	
çSph  	çS1P products 	
Figure 3.15 – TLC analysis of SPHK1 catalyzed phosphorylation/ biotinylation of Sph 
with ATP (lane 5), ATP-biotn (lane 6) and ATP-O-biotin (lane 7). After 1 hr incubation 
at 30 oC, 1-butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) mobile phase was  used 
for separation. Anisaldehyde stain was used to visualize the speared components. 
Repetitive trial is shown in Figure B.8. 
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stable phosphobiotinyl modification does not play a significant role in changing the Rf of 
the biotinylated product.  
3.2.3.2 Kinase-catalyzed labeling of Sph with carbon-linked ATP analogs 
In addition to oxygen linked ATP analogs, it is reported that carbon linked γ -
phosphate modified ATP analogs are also stable through pH range of 2-12.171 Thereby, 
carbon linked ATP analogs with a biotin or fluorophore modification would be an ideal 
cosubstrate for TLC separation of modified Sph under acidic conditions. To establish the 
synthesis of carbon-linked ATP analogs, ATP-CH2-heptyl (3), was synthesized and 
SPHK1-catalyzed labeling was performed. 
3.2.3.2.1 Synthesis of ATP-CH2-helptyl (3) 
ATP-CH2-heptyl (3) was synthesized as follows. 1-Bromoheptane (9) was 
reacted with triethyl phosphite and the product diethyl heptylphosphonate (10) was 
purified by vacuum distillation (Scheme 3.2). Next, reacting phosphonate (11) with 
TMSBr yielded heptylphosphonic acid (11). The product was coupled with the n-butyl 
ammonium salt of ADP (12) (activated by CDI) to give 3, which was purified by DEAE 
sephadex column with a gradient elution with TEAB buffer. 
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3.2.3.2.2 Kinase-catalyzed labeling of Sph with ATP-CH2-helptyl (3) 
Sph was incubated with ATP-CH2-heptyl  (3) and SPHK1 (Figure 3.16 A, lane 2) 
and the reaction products were compared with the products of ATP reaction (Figure 
3.16 A, lane 4). C-linked phosphorylation on sphingosine is considered to be stable to 
the acidic TLC conditions and would exhibit a different Rf value than S1P due to the 
heptyl group on the phosphate. The kinase reaction with compound 13 did not show any 
significant shift or new spot (Figure 3.16 A, lane 2). In order to remove interference by 
the non-lipid components of the reaction mixture, the Sph derivatives were isolated with 
chloroform/methanol extraction. The products were analyzed by TLC and still no new 
spot was observed (Figure 3.15 B, lane 2).  
  
Scheme 3.2 – Synthesis of ATP-CH2-heptyl  (3) 
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There are distinct structural features that have to be taken in to consideration as 
to why the carbon-linked ATP analog did not give phosphoryl-modified Sph as natural 
ATP. The first feature is that, the heptyl group is linked to the γ–phosphate of ATP via a 
C-P bond and the terminal phosphate lacks an oxygen atom, which is present in natural 
ATP. Therefore, the binding of the triphosphate moiety of the cosubstrate of the carbon-
linked analog may be different from the natural ATP. Due to the differences in the 
interactions of the γ–phosphate with the cofactor Mg2+ and amino acid side chains of the 
ATP-binding cleft of SPHK1, ATP-CH2-heptyl might not be accepted as a cosubstrate to 
 1 2 3 4 5 6 7  1 2 3 4 5 6 7 
Sph + + + + - - +  + + + + - - + 
S1P - - - - - + -  - - - - - + - 
ATP - - + + - - -  - - + + - - - 
ATP-CH2-heptyl + + - - + - -  + + - - + - - 
SPHK1 + + + + - - -  + + + + - - - 
çSolvent 
front 	
çOrigin 
(ATP/ATP 
analog) 	
çSph  	
çS1P 
products 	
Figure 3.16 – TLC analysis of SPHK1 catalyzed phosphorylation/ 
phosphorylheptylation of Sph with ATP (lane 4) or ATP-CH2-helptyl (lane 2). After 1 hr 
incubation at 30 oC, 1-butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) mobile phase 
was  used for separation. Anisaldehyde stain was used to visualize the separated 
components. Either A) Crude reactions or B) Chloroform-extracted reactions were 
separated by TLC. Repetitive trial shown in Figure B.17. 
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phosphoryl modify Sph. On the other hand, the nitrogen-linked (ATP-biotin 1 and ATP-
dansyl 2) and oxygen-linked (ATP-O-biotin 1B) discussed in previous sections lead to 
“S1P-like” new product, showing that they are accepted as a cosubstate by SPHK1. 
Unlike carbon, the lone pairs on nitrogen and oxygen atoms attached to the γ –
phosphate might be facilitating the binding of the ATP analogs to the catalytic domain, 
similar to natural ATP. Hence, successful transfer of modified γ –phosphate might have 
achieved. The second noteworthy feature of ATP-CH2-heptyl is the difference in the 
linker compared to biotin and dansyl modified analogs. ATP-CH2-heptyl consists of a 
straight heptyl carbon chain while the other analogs consist of a PEG linker or a 5-
carbon linker attached to bulky substituents (biotin and dansyl groups). Therefore, the 
hydrophobicity of the heptyl group may be different from the other ATP-analogs, which 
may lead to no reactivity of ATP-CH2-heptyl. Although docking studies were not 
performed on these analogs with SPHK1, the above-mentioned speculations may 
explain why ATP-CH2-heptyl was not accepted as a cosubstrate.  
3.2.4 Study of the effect of phosphatase towards phosphorylation/  
phosphobiotinylation of Sph 
Previous work shows that thiophosphoryl174 and phosphobiotinyl90 groups on 
proteins/ peptides are insensitive to phosphatases. It is difficult to distinguish 
phosphorylation from phosphobitinylation of sphingosine by Rf values of the TLC 
(Section 3.6). Inspired by the previous phosphatase experiments90 on proteins by Dr. 
Chamara Senevitathne from our lab, the presence of phosphobiotinylation was 
examined by phosphatase treatment of Sph after the kinase reaction. If S1P-biotin 
product is stable upon phosphatase treatment, the TLC separation would show Rf ~ 0.7 
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product remain unhydrolyzed (Figure 3.17 B) while S1P product (from natural ATP) will 
be disappeared upon phosphatase treatment (Figure 3.17 A).  Here, Sph was phospho-
modified with SPHK1 (with ATP and ATP-biotin in separate reactions) and the kinase 
was heat denatured at 65oC prior to calf intestinal phosphatase (CIP) 
dephosphorylation. When the crude reactions were separated by 1-
butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) mobile phase, CIP and SPHK1 spots 
were overlapping with Sph-related spots. Therefore, after the phosphatase reaction, the 
lipid components were purified by chloroform extraction and separated by TLC. 
Anisaldehyde stain was used to visualize the sphingosine products.  
In the ATP reaction, before phosphatese treatment, 47% conversion of Sph (Rf ~ 
0.7) to S1P (Rf ~ 0.6) was observed (Figure 3.18 A, lanes 4 and 5). Upon phosphatase 
treatment, the S1P product has completely converted back to Sph after 1 hr incubation 
Figure 3.17 – A) Hydrolysis of S1P upon CIP treatment to Sph and Pi B) S1P-
biotin will not dephosphorylate to biotin-phosphoramidate and Sph upon CIP 
treatment 
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at 37 Co (Figure 3.18 A, lanes 1 and 2). However, for the ATP-biotin reaction, only a 9% 
conversion of phosphoryl modified Sph (Rf ~ 0.6) was observed after chloroform 
extraction, which was poorly visible upon anisaldehyde staining (Figure 3.18 B, lane 10). 
Although the modified Sph was expected to remain unchanged upon CIP treatment, 
there was no visible Sph product with Rf ~ 0.6 after lipid extraction (Figure 3.18 B, lane 
8). As the percentage conversion for ATP-biotin is low compared to natural ATP, the 
sensitivity of TLC analysis is sufficient only for the monitoring of effect of CIP on ATP 
reaction but not for ATP-biotin reaction. Thereby, more sensitive analytical method to 
qualitatively and quantitatively characterize the kinase catalyzed labeling should be 
employed.  
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 1 2 3 4 5 6  7 8 9 10 5 6 
Sph + + + + - +  + + + + - + 
S1P - - - - + -  - - - - + - 
ATP + + + + - -  - - - - - - 
ATP-biotin - - - - - -  + + + + - - 
CIP + + - - - -  + + - - - - 
SPHK1 - + - + - -  - + - + - - 
çSolvent 
front 	
çOrigin 
(ATP/ATP 
analog) 	
çSph  	
çS1P 
products 	
A. B. 
Figure 3.18 – TLC analysis of the effect of phosphatase on SPHK1 catalyzed 
phosphorylation/ phosphorylbiotinylation of Sph. After kinase catalyzed 
labeling, followed by CIP treatment, the lipids were purified by chloroform 
extraction. 1-butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) mobile phase 
was  used for separation. Anisaldehyde stain was used to visualize the 
speared components. A) ATP reaction B) ATP-biotin reaction. Repetitive trial 
is in Figure B.18. 
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3.2.5 Mass spectrometric analysis of kinase catalyzed labeling of Sph 
 Mass spectrometry has become one of the leading techniques used in lipidomics 
analysis.175 MALDI mass spectrometry is a laser-based soft-ionization method often 
used for analysis of large proteins, but has been used successfully for lipids.176,177 The 
lipid is mixed with a matrix, such as 2,5-dihydroxybenzoic acid, and applied to a sample 
holder as a small spot. MALDI-Time-of-flight (MALDI-TOF) MS has become a very 
promising approach for lipidomics studies, particularly for the imaging of lipids from 
tissue slides.  Since Sph and S1P are in low molecular weight region, the molecular ion 
peak was difficult to observe in MALDI-TOF analysis of the crude reactions of kinase 
catalyzed labeling with γ–phosphate modified ATP analogs. The same problem was 
encountered in ESI-MS analysis as well. 
To overcome the poor ionization, the SPHK1-catalyzed crude reactions of ATP 
and ATP-biotin with sphingosine were analyzed by Matrix assisted ionization vacuum 
(MAIV)178 with 3-nitrobenzonitrile (3-NBN) matrix, which is a new technique developed 
by Dr. Trimpin’s lab at Wayne State University, Chemistry department. The main 
advantage of the MAIV method is that it makes the analyte transported directly from a 
solid-state small molecule matrix to gas-phase ions when placed into the vacuum of a 
mass spectrometer without the use of high voltage, a laser, or added heat. Thereby, the 
cleavage of the phosphoramidate bond of biotin modified Sph might not take place and 
the molecular ion of S1P-biotin can be identified by MS. As complex biological samples 
are successfully detected within a broad detection range, characterization of Sph and its 
derivatives could be successfully achieved compared to MALDI and ESI-MS. 
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With this method, the presence of S1P in both ATP and ATP-biotin reactions was 
observed, confirming a phosphorylation in both cases in positive mode (Figure 3.19A). 
However, the phosphobiotinylated product was not observed under these conditions 
(Figure 3.19B). Instead the data showed the presence of biotin amine (Figure B.21) 
which is the by-product given after cleaving the phosphoramidate bond of a 
phopsphobiotinylated compound. The results suggest that the phosphorylbiotin group 
may have been cleaved off during ionization in vacuum during mass spectrometric 
analysis. If not, the biotin amine may have been generated as a degradation product of 
the starting material, ATP-biotin. The data obtained by current MAIV analysis suggests 
that the analytical method should be further optimized such that ATP-biotin or S1P-
biotin would not degrade upon ionization.  
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Figure 3.19- MAIV data for ATP rxn vs. ATP-biotin rxn for Sph in positive mode with 
3-NBN matrix. [M+1]+ calculated: Pure Sph –300.28 m/z, S1P – 380.24 m/z, S1P-
biotin– 808. 49 m/z, Biotin amine– 447.26 m/z) A) Both ATP-biotin (top) and ATP 
(bottom) reactions indicates the presence of S1P product. B) SPHK1 catalyzed 
biotinylation reaction does not indicatethe presence of S1P-biotin product formation 
(top). Repetitive trial is shown in Figures B.19, B.20, and B.21. 	
B. 
A. 
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3.2.6 Study of the stability of ATP-biotin in the presence of SPHK1  
 In order to see whether the kinase caused degradation of γ–phosphate modified 
ATP to generate ATP that would compete against the modified ATP analogs during 
phosphorylation, a comparison experiment was performed (similar to section 2.2.2.5 in 
chapter 2). Herein, both ATP and ATP analogs were incubated with SPHK1 in the 
absence of Sph substrate and TLC analysis was performed to monitor the degradation 
of ATP analog. The TLC provided evidence that no degradation of ATP analog takes 
place during the incubation (Figure 3.20) suggesting that there’s no in situ generation of 
ATP taking place by the kinase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 1 2 3 4 5 6 
ATP - - + + + - 
ATP-biotin + + - - - + 
SPHK1 - + - + - - 
Kinase buffer + + + + + + 
çSolvent front 	
çSPHK1 	çATP-biotin 	
çATP 	
Figure 3.20 - Study of the stability of ATP-biotin in the presence of whrere ATP-
biotin was incubated with SPHK1 kinase for 1 hr at 30 oC and analyzed by TLC. 
NO degradation of ATP and ATP-biotin was observed upon incubation with 
SPHK1. 
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3.3 Conclusions and discussion 
 The data for kinase-catalyzed labeling of Sph with ATP-biotin 1 suggests that 
SPHK1 accepts ATP-biotin as a cosubstrate in phosphoryl midifying Sph substrate. But 
the presence of biotinyl modification on the substrate was not confirmed with any of the 
analytical approaches used. Instead the product S1P has been observed, indicating the 
degradation of phosphoramidate bond is taking place on the modified substrate. Similar 
consequences were obtained for the other tested γ–phosphate modified ATP analogs 
as well. The present data suggests that the current analytical techniques (TLC and MS) 
are not sensitive in characterizing (qualitatively and quantitatively) the kinase catalyzed 
labeling by SPHK1. To overcome this challenge, current approaches should be further 
optimized and further studies on Sph labeling should be performed.  
As Sph plays an important role cell-signaling pathway, developing of a non-
radioactive labeling method of Sph by SPHK1 would have a broader impact on studying 
the kinase activity. As a future direction, a plate-based assay can be developed to 
screen novel SPHK1 inhibitors and the biotinyl or fluorophore modification can be used 
to quantify the activity of the kinase instead of scintillation counting in radiolabeled 
assay. Here in, the plate-based assay can be developed using recombinant SPHK1 and 
with increasing concentration of inhibitors the reaction can be monitored. With the 
fluorophore-modified ATP analog, the reaction can be quantified by the florescence 
signal. Whereas for ATP-biotin based plate assay, activity of SPHK1 inhibitors can be 
monitored by incorporating streptavidin-fluorophore conjugate, to quantify the 
biotinylation of sph. This non-radiocative plate based assay can be used to generate 
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IC50 values of the SPHK1 inhibitors. Once the plate-based assay is established, the 
studies can be further expanded towards live cell lysates to study the inhibitor activity in 
biological samples. Also, ATP analogs with a photocrosslinker can be employed in 
identifying unprecedented proteins, which are involved with cell signaling cascades of 
Sph.  
 The initial kinase catalyzed labeling and characterization will lead to future work 
where lipids that present in complex biological samples could be labeled by kinase-
mediated reactions.  In addition to SPHK1, other lipid kinases such as PI3K which are 
becoming an interesting targets in drug development, and the expansion of a chemical 
tool to label lipid kinases would provide a new platform in understanding the functions of 
lipid kinases in cell signaling. 
3.4 Experimental Section 
3.4.1 Materials 
ATP-biotin was obtained by the synthesis explained in Chapter 2. Triethylamine, 
1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), 4, 7, 10-trioxa-1, 
13-tridecanediamine, diisopropylethylamine (DIPEA), N, Ndimethylformamide (DMF), p-
anisaldehyde, 1-Bromoheptane, and triethylphosphosphite were purchased from Acros. 
Ethylenediaminetetraacetic acid (EDTA), 3-morpholinopropane-1-sulfonic acid (MOPS), 
ethylenediaminetetraacetic acid (EDTA), dithiothreitol (DTT), adenosine 5’- triphosphate 
(ATP), glycerol, sodium hydroxide (NaOH), potassium chloride (KCl), magnesium 
chloride (MgCl2), sodium chloride (NaCl), Chloroform, Methanol, Ethanol, 
Dichloromethane, and SA-Cy5 conjugate were purchased from Fisher. HPLC grade 
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trifluoroacetic acid (TFA) and acetonitrile were obtained from VWR and EM Millipore, 
respectively. D2O and CD3OD were obtained from Cambridge Isotope Labs. Potassium 
Chloride (KCl), pentane-5-amine-1-ol, phosphorus oxychloride, magnesium sulfate 
(MgSO4) were bought from Sigma. Sphingosine kinase 1 (SPHK1) and D-erythro-
Sphingosine (Sph) were bought from Cayman Chemical. Calf Intestinal Phosphatase 
(CIP) was purchased from New England Bio-labs. ADP-Glo assay was obtained from 
Promega. Thin layer chromatography plates were purchased from Millipore. 
3.4.2 Instrumentation 
1H NMR and 13C NMR and were recorded on Varian Mercury (400 MHz) 
spectrometer. The peaks appearing at δ 4.78 and δ 5.12 in 1H NMR are due to D2O. 
The signals appearing at δ 1.58 and δ 3.52 in the 1H NMR and δ 8.2 and δ 46.4 in the 
13C NMR are due to the triethylamine counter ion. HPLC purification of ATP analogs 
was performed using a Waters 1525 binary HPLC pump, Waters 2998-photodiode-array 
detector, and reverse phase C-18 column (YMC America, INC 250Å~4.6 mm, 4μm, 8 
nm). The purified ATP analogs were lyophilized using VirTis BT 3.3 EL Benchtop 
lyophilizer. A SPD131 DDA ThermoSavant speed vac was used to evaporate solvents in 
vacuo. The concentration of the ATP analog was calculated using the Varian Cary 50 
UV-Vis spectrophotometer. The luminescence values for the ADP-Glo assay were 
measured with a fluorimeter (GENios Plus Tecan). A Thermo Scientific-Pierce UVP 3UV 
Ultraviolet lamp was used for the visualization of TLC spots. The mass spectrometric 
analysis of SPHK1-catalyzed labeling of Sph performed using a MALDI-TOF MS 
(Bruker Ultraflex). Matrix Assisted Ionization Vacuum (MAIV) analysis was performed on 
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a commercial atmospheric pressure ESI Source (SYNAPT G2) with 3-Nitrobenzonitrile 
(3-NBN) matrix.  
3.4.3 ADP-Glo™ kinase assay analysis for SPHK1 
In a 96-well white plate, SPHK1 (2 ng/µL) was mixed with sph (100 µM) in 
SPHK1 buffer (5 mM MOPS, pH 7.2, 0.5 mM dithiothreitol (DTT), 5 mM MgCl2, 0.02 mM 
EDTA, and 4% methanol,). The kinase reaction was initiated by adding ATP or ATP-
biotin (200 µM). Final volumes of the reactions were 25 µL. The reactions were 
incubated at 31 oC for 1 hr and then terminated by adding ADP-Glo™ reagent (25 µL) 
and incubating at room temperature for 40 min. Kinase detection reagent (50 µL) was 
added and the reaction was incubated for 30 min at room temperature. Finally, 
luminescence signal was measured using a microplate reader (GENios Plus, Tecan).  
The mean luminescence signal and standard error from three independent trials is 
displayed in Figure 3.7 and Table B.1 
3.4.4 Kinase catalyzed phosphorylation/ labeling of Sph  
Sph (200 µM) substrate was mixed with ATP or ATP-analog (1 mM), and SPHK1 
enzyme (8 ng/µL) in SPHK1 buffer was added in a 25 µL total volume. The reaction was 
mixed well by pipetting and incubated at 31oC for 1.5 hrs without shaking.  Critical 
controls included reactions where SPHK1 or ATP-analog was omitted.  The reactions 
were analyzed as described below.   
3.4.5 CIP treatment of kinase-catalyzed labeled Sph 
The kinase reaction (section 3.4.4) was heated at 65 oC for 20 mins to heat 
denature the kinase. Next, manufacturer provided buffer 3 (Promega), CIP (0.4 
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units/µL), and water was added to obtain a total 30 µL volume. The reaction was mixed 
well with pipetting and heated at 37 oC for 2 hrs. 
3.4.6 Chloroform extraction of Sph 
 The kinase-catalyzed reaction (25 µL, section 3.4.4) was diluted to 100 µL with 
distilled water. To the 100 μL reaction mixture, 270 µL of chloroform/methanol (1:2) and 
20 µL of 5M KCl was added. The addition of KCl enhances the extraction of S1P to the 
organic layer. Next, 70 µL of chloroform was added to create a phase separation and 
the mixture was vortexed well. The mixture was centrifuged for 5 min at 13,000 × g to 
fully separate the phases and the upper aqueous/methanol phase was removed by 
pipetting. The remaining ~160 µL of chloroform layer volume was reduced by speed 
vac. to 10 µL final volume.  
3.4.7 TLC analysis of kinase-catalyzed biotinylation by SPHK1 
 First, the sides of the TLC tank were lined with filter paper and wetted with mobile 
phase while covering the bottom of the TLC tank to approximately 0.5 cm height. Next a 
clean TLC plate (height ~ 6 cm and width changed depending on the number of spots) 
was placed on the hot plate, silica side up for approximately three minutes to activate 
the silica. The Sph products and the controls were spotted at 0.75 cm above the bottom 
of the plate. The spots were air-dried and the TLC plate was placed it in the tank. The 
TLC was allowed to develop until the solvent front reached 0.5 cm from the top edge of 
the plate. The excess solvent from the plate was removed by placing on a hot plate and 
visualized by short (254 nm) and long wavelength (365 nm) UV light. For staining, the 
dried plate was dipped in anisaldehyde (for amines) or molybdenum blue (for 
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phosphates) stain. The TLC plate was placed on the hot plate until the spot color 
developed. The mean Rf values and percentage conversions were calculated from three 
independent trials. 
3.4.7.1 Preparation of the anisaldehyde stain 
First, acetic acid (15 mL) was mixed with p-Anisaldehyde (3.5 mL) and was 
added to ice cold ethanol (350 mL). Next, conc. Sulfuric acid  (50 mL) was added drop 
wise, mixed carefully and stored at 4°C.  The TLC plates were dipped in the stain, air-
dried and heated on a hot plate until the spots are developed. 
3.4.7.2 Preparation of the molybdenum blue stain 
First, Solution I was prepared by boiling MoO3 (4.01g) in 25N sulfuric acid (100 
mL) until the molybdenum oxide was completely dissolved. The light yellow solution was 
allowed to cool slowly to ambient temperature overnight. Solution II was prepared by 
boiling molybdenum powder (0.17 g) in solution I (50mL) for 15min. The stain was 
prepared by mixing solution 1, solution 2, and water with 2: 2: 9 ratio and used fresh. 
The solutions I and II can be stored for a long time in the dark at room temperature. The 
TLC plates were dipped in the stain, air-dried and heated on a hot plate until the spots 
developed. 
3.4.8 TLC spot quantification 
The stained TLC spots were quantified using ImageJ v1.49 by drawing the same 
size rectangular/ circular shape around the spot area. The background correction was 
calculated by subtracting the signal of the TLC plate with no spot from the selected 
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signal from TLC spot. The percentage conversion of S1P or S1P-label were calculated 
by dividing the intensity of the new spot from total starting Sph spot.  
3.4.9 Synthesis of ATP-dansyl (2) 
3.4.9.1 Synthesis of dansyl amine (8) 
Dansyl chloride (7) (0.27g, 1 mmol) was dissolved in dichloromethane (50 mL) 
and added dropwise to 4,7,10-trioxa-1-13-tridecanediamine 5 (0.44 mL, 2.5mmol) in 
DCM (20 mL) for 3 hrs at 0 oC. The reaction was stirred for 8 hrs and was monitored by 
TLC (6:2:1 Ethanol:DCM:NH4OH, Rf= 0.54). The reaction was concentrated in vacuo 
and the product was purified on silica column using ethanol/DCM (3:1 v/v) as mobile 
phase to obtain dansyl-PEG-amine (8), as a yellow oil (0.403 g, 89%) yield. ESI-MS: 
m/z calculated for C18H27N3O2S [M+H] = 350.2, observed 350.4 (Figure B.4) 
 
3.4.9.2 Synthesis of ATP-dansyl (2) 
Adenosine 5’-triphosphate disodium salt (27.5 mg, 0.05 mmol, 1.0 eq) was 
dissolved in water (5 mL) in a 50mL falcon tube and 1-(3-Dimethylaminopropyl)-3- 
ethylcarbodiimide hydrochloride (383.42 mg, 2 mmol, 40 eq) dissolved in water (1 mL) 
was added to it. The pH was adjusted to 5.6 with 1M hydrochloric acid and dansyl-PEG-
amine (0.37 mg, 1 mmol, 20 eq) dissolved in minimum amount of water was added 
while maintaiing the pH range of 5.6-5.8. Progress was monitored by TLC (6:3:1 iPrOH: 
NH4OH: H2O, Rf =0.72). The reaction was stirred for 2.5 hours and the product was 
purified by RP-HPLC (buffer A: 0.1M TEAA pH 7.0, buffer B: acetonitrile) using a binary 
system with a gradient of buffer A 95%- 60% over 40 minutes. The product was eluted 
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at 39 min and lyophilized to obtain 7% of ATP-dansyl 2 as a white TEA salt (0.003 g, 
7%). 1H NMR (400 MHz, D2O): δ 1.16 (4H, m), 1.96 (4H, m), 2.91 (6H, s), 3.17 (4H, t), 
3.21-3.42 (8H, m), 7.34 (1H, m), 7.57 (1H, m), 8.22 (1H, d), 8.37 (1H, d), 8.58 (1H, d). 
MALDI-TOF-MS: m/z calculated for C28H41N8O14P3S [M+H]+ = 839.17, observed 839.00, 
m/z calculated for C28H41N8O14P3S [M-H]- = 837.17, observed 837.34 (Figure B.5 and 
B.6) 
3.4.10 Synthesis of ATP-CH2-heptyl (3) 
3.4.10.1 Synthesis of diethyl heptylphosphonate (10) 
In a 50 mL RB flask under nitrogen equipped with a distillation setup, 
triethylphophite (17.14 mL, 100 mmol) and 1-bromoheptane (9) (7.85 mL, 50 mmol) 
were mixed. The reaction mixture was heated at 140 oC for 4 hrs. The resulting 
byproduct bromoethane was distilled off (~3 mL). Then the reaction mixture was cooled 
to room tempereature and distilled under vacuum (bp 175-180 oC in 11 mmHg) affording 
phosphonate (10) as colorless oil (8.97 g, 76%). 1H NMR (400 MHz, DMSO): δ 0.79 
(2H, t), 1.28-1.37 (14H, m), 1.61 (2H, m), 1.72 (2H, m), 4.17 (4H, m).13C NMR (100 
MHz, DMSO): δ 14.02, 16.48, 22.40, 24.98, 26.37, 28.73, 30.46, 31.55, and 61.28 (1C). 
3.4.10.2 Synthesis of heptylphosphonic acid (11) 
TMSBr (1.0 mL, 7.8 mmol) was added to anhydrous CH2Cl2  (10 mL) and 
compound 10 (1.3 mL, 1.3 mmol) was added at 0 oC and stirred at room temperature for 
12 hrs. Solvent was evaporated under reduced pressure and water (15 mL) was added 
and stirred for 10 hrs. The reaction was extracted with ethyl acetate and washed with 
water followed by saturated NaCl solution. The product was dried over MgSO4.  
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Removal of solvent gave a white solid (11) (0.157 g, 67%). 1H NMR (400 MHz, DMSO): 
δ 0.92 (3H, t), 1.13-1.27 (8H, m), 1.28- 1.43 (2H, m), 10.27 (2H, s).13C NMR (100 MHz, 
DMSO): δ 14.03, 21.98, 22.57, 28.70, 30.28, 30.44, and 31.54 (1C). 
3.4.10.3 Synthesis of ATP-CH2-Heptyl (3) 
Adenosine 5’- diphosphate tetrabutyl ammonium salt (12) (0.066 mmol, 1.0 eq) 
dissolved in dry DMF (5 mL) and CDI (0.33 mmol, 5 eq) was stirred for 10 hrs. Methanol 
(0.3 mL) was added and stirred for 1 hour. Next, triethylamine (0.2 mL) and (11) (0.33 
mmol, 5 eq) was added and stirred for 8 hrs. Progress was monitored by TLC (6:3:1 
iPrOH: NH4OH: H2O Rf =0.72). The product was purified by DEAE sephadex anion-
exchange chromatography stepwise elution using 5%, 10%, 25%, 37.5%, 50%, 75% 
and 100% triethyl ammonium bicarbonate buffer (1 M TEAB). Compound 3 eluted at 
37.5% buffer. The product was lyophilized to obtain ATP-CH2-heptyl 3 as a white TEA 
salt (13 mg, 33%).1H NMR (400 MHz, D2O): δ 1.01-1.07 (4H, m), 1.19-1.23 (2H, t), 1.78 
(1H, s), 2.91-2.96 (2H, m), 3.19 (1H, t), 3.43-3.48 (2H, m), 3.50-3.54 (4H, m), 4.12 (1H, 
s), 4.27 (1H, s), 4.43 (1H, s), 6.04-6.06 (1H, d), 8.31 (1H, s), 8.56 (1H, s). 13C NMR (100 
MHz, D2O): δ 13.32, 17.57, 21.90, 22.40, 26.41, 26.70, 27.99, 29.89, 30.94, 65.02 and 
69.51 (1C), 70.26 and 74.62 (1C), 84.42 and 87.72 (1C), 120.72, 121.87, 126.84, 
137.57. 31P NMR (162 MHz, D2O): δ 21.57-21.73 (d), -11.70 to -11.57 (d), -23.35 (t). 
HRMS (ESI): m/z calculated for C17H30N5O12P3 [M-H]- 588.11, observed 588.1028. 
3.4.11 MALDI-TOF analysis of kinase catalyzed labeling of Sph 
The matrix was prepared by mixing 3-NBN (5	μg) in a 50:50 ACN: water mixture 
(20 μL). The chloroform-extracted Sph sample (Section 3.4.6) was fully dried in a speed 
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vac and dissolved in methanol (3 μL). The Sph (1 μL) sample and the matrix (1 μL) 
were mixed well by pipetting and the mixture (1 μL) was spotted on the target plate. 
After solvent evaporation of the analyte–matrix spot, the MALDI target plate was 
introduced into the mass spectrometer and the analysis was performed. (Instrument 
type- Ultraflex, Acquisition operation mode- Reflector, Reflection voltage- 20.29999 V, 
Number of shots- 100, Laser repetition rate- 20 psec) 
3.4.12 MAIV analysis of kinase catalyzed labeling of Sph 
 The sample preparation was similar to MALDI analysis. Instead of spotting the 
sample on the target plate, the matrix-sample mixture (1 μL) was dried on a plastic pipet 
tip and placed on the ferrule facing the source entrance. The vacuum isolation valve 
was opened and the pipet tip was held to the ferrule and the sample was introduced by 
the pressure differential between the atmospheric pressure and the instrument vacuum. 
Ions were observed until the matrix was no longer visible on the pipet tip (Polarity- LDI+, 
Analyzer- Sensitivity mode, Sample plate 0.0, Maldi extraction- 10.0). 
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APPENDIX A: STUDYING THE COSUBSTRATE PROMISCUITY OF NUCLEOTIDE 
KINASES 
 
 
 
 
 
  
Figure A.1- 1H-NMR of ATP-biotin 7 recorded in D2O solvent. 
Figure A.1- MALDI-TOF MS of ATP-biotin (1) with 3-HPA matrix in negative mode. 
MALDI-TOF MS: m/z calculated for C30H51N9O17P3S [M-H]- 934.23, observed 934.940.  
 
Figure A.2- 1H-NMR of ATP-biotin (1)  recorded in D2O solvent. 
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 Trial 1 Trial 2 Trial 3 Mean Standard Error 
28-mer 930 619 690 746 94 
28-mer + T4 2611 1926 2319 2285 198 
28-mer + ATP 1268 1053 1058 1126 71 
T4 + ATP 41969 33117 37763 37616 2556 
28-mer + ATP + T4 73628 57165 65163 65319 4753 
28-mer + ATP-biotin 4875 3943 4526 4448 272 
T4 + ATP-biotin 13516 10239 11915 11890 946 
28-mer + ATP-biotin + T4 21368 16518 19069 18985 1401 
Figure A.3- Percentage purity of ATP-biotin (1) analyzed by RP HPLC analytical 
column (buffer A: 0.1M TEAA pH 7.0, buffer B: Acetonitrile) using a binary 
system with a gradient of buffer A 95%- 60% over 40 minutes. ATP- 6.6 min 
(1.3%), ADP- 9.3 min (0.8%), and ATP-biotin- 25.1 min (97.9%) 
Table A.1.  Raw data for the ADP-Glo assay, including three independent trials, 
mean, and standard error, which are plotted in Figure 2.6 of Chapter 2. 
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A. 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.4 –MALDI-TOF MS analysis of T4 PNK catalyzed 5’-biotinylation of a 14mer 
single stranded DNA (5′-GGGTGGCCTTGTCC- 3′) in negative ion mode. A) Second 
trial, 5′-Phosphorylated-14mer: calculated [M-H]— 4366.9 m/z, observed 4366.792 m/z. 
B) Third trial, 5′-Phosphorylated-14mer: calculated [M-H+Na]— 4390.9 m/z, observed 
4390.070 m/z. In all three trials, 5′-P-biotin-14mer calculated [M-H]—: 4795.2 m/z was 
not observed. 
  
4366.792 m/z 
5’-P-14mer+ Na+ 
4390.070 m/z 
5’-P-14mer 
4367.637 m/z 
5’-P-14mer 
4366.723 m/z 
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Figure A.5 – Quantitative gel analysis with the 28-mer DNA.  A-B) Additional two trials 
and controls with contents of each lane and conversion percentages indicated. A 
synthetic single stranded DNA containing a 5′-biotin group was included for comparison 
(biotin-DNA). The DNA of crude reactions were separated by denaturing urea gel 
electrophoresis and visualized with SYBR Gold (Invitrogen). C) Percentage conversions 
observed with the three independent trials (Figure 2.9 A and parts A and B), with mean 
and standard error shown.   
 
 
 
  
 1 2 3 4 5 6 7 
ssDNA + - + + + + + 
biotin-DNA - + - - - - - 
ATP - - - + - + - 
ATP-biotin - - - - + - + 
T4 PNK - - + - - + + 
% conversion - - - - - 53 38 
 1 2 3 4 5 6 7 
ssDNA + - + + + + + 
biotin-DNA - + - - - - - 
ATP - - - + - + - 
ATP-biotin - - - - + - + 
T4 PNK - - + - - + + 
% conversion - - - - - 43 37 
 Trial 1 Trial 2 Trial 3 Mean Standard error 
ATP reactions 52 53 43 49 3 
ATP-biotin reaction 45 38 37 40 2 
A. 
B. 
C. 
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Figure A.6 – Quantitative gel analysis with the 37-mer DNA.  A-B) Additional two trials 
and controls with contents of each lane and conversion percentages indicated. A 
synthetic single stranded DNA containing a 5′-biotin group was included for comparison 
(biotin-DNA). The DNA of crude reactions were separated by denaturing urea gel 
electrophoresis and visualized with SYBR Gold (Invitrogen).  C) Percentage conversions 
observed with the three independent trials (Figure 2.9 B and parts A and B), with mean 
and standard error shown. 
 
 
 1 2 3 4 5 6 7 
ssDNA + + + + + + - 
biotin-DNA - - - - - - + 
ATP - - + - + - - 
ATP-biotin - - - + - + - 
T4 PNK - + - - + + - 
% yield - - - - 48 41 - 
 1 2 3 4 5 6 7 
ssDNA + + + + + + - 
biotin-DNA - - - - - - + 
ATP - - + - + - - 
ATP-biotin - - - + - + - 
T4 PNK - + - - + + - 
% yield - - - - 45 40 - 
 Trial 1 Trial 2 Trial 3 Mean Standard error 
ATP reactions 49 48 45 47 1 
ATP-biotin reactions 44 41 40 42 1 
A. 
B. 
C. 
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  Trial 1 Trial 2 Mean Standard error 
5′-A ATP reaction 58 48 53 5 
ATP-biotin reaction 60 27 44 16 
5′-C ATP reaction 70 63 67 4 
ATP-biotin reaction 63 57 60 3 
5′-T ATP reaction 72 51 62 10 
ATP-biotin reaction 56 40 48 8 
5′-G ATP reaction 47 46 47 1 
ATP-biotin reaction 43 42 43 1 
 
Figure A.7 – Quantitative gel analysis with the 28-mer DNA containing A, C, T, or G at 
the 5′-end (5′-NACCGTAGGCAAGAGTGTGCTTTTTTTTT-3′).  A) Additional trial and 
controls with contents of each lane and conversion percentages indicated. A synthetic 
single stranded DNA containing a 5′-biotin group was included for comparison (biotin-
DNA). The DNA of crude reactions were separated by denaturing urea gel 
electrophoresis and visualized with SYBR Gold (Invitrogen). C) Percentage conversions 
observed with the independent trials (Figure 2.10 and part A), with mean and standard 
error shown. 
 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
28mer 5′-N  - A A A C C C T T T G G G 
biotin-DNA + - - - - - - - - - - - - 
ATP -  - + - - + - - + - - + - 
ATP-biotin - - - + - - + - - + - - + 
T4PNK - - + + - + + - + + - + + 
% conversion - - 48 27 - 63 57 - 51 40 - 46 42 
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Figure A.8 - Additional Southern blot trials. Analysis of the 417-mer PCR amplified 
product generated using a 37-mer primer that was subsequently reacted with the 
components indicated below the lane. Total DNA was visualized by SYBR gold stain 
and biotin-modified DNA was visualized using a streptavidin-Cy5 (SA-Cy5) conjugate.  
As a positive control a 37-mer primer containing a 5’biotin group (biotin-DNA) was used 
(lane 2). Two independent trials are shown in A and B, with the third trial shown in 
Figure 2.11.   
  
 1 2 3 4 
37mer + - + + 
biotin-DNA - + - - 
ATP-biotin - - - + 
ATP - - + - 
T4PNK - - + + 
 1 2 3 4 
37mer + - + + 
biotin-DNA - + - - 
ATP-biotin - - - + 
ATP - - + - 
T4PNK - - + + 
SYBR gold 
 
 
SA-Cy5 
 
SYBR gold 
 
 
SA-Cy5 
 
B. 
A. 
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Figure A.9 - Additional dot blot trials. A) Analysis of the 417-mer PCR amplified product 
generated using a 37-mer primer that was subsequently reacted with the components 
indicated below the lane. Total DNA was visualized by SYBR gold stain (top) and biotin-
modified DNA was visualized using a streptavidin-Cy5 (SA-Cy5) conjugate (bottom).  As 
a positive control a 37-mer primer containing a 5′-biotin group was used (lane 6). Two 
independent trials are shown  B) The level of biotinylation was quantified by comparing 
to the biotin-DNA positive control (lane 6), which was set to 100%.  The mean and 
standard error of three independent trials (Figure 2.12 and part B) is shown. 
 
  
 1 2 3 4 5 6 
37-mer + + + + + - 
biotin-DNA - - - - - + 
T4 PNK - + - + - - 
ATP + + - - - - 
ATP-B - - + + - - 
Trial 2 - - - 13 - - 
Trial 3 - - - 9 - - 
 Trial 1 Trial 2 Trial 3 Mean Standard error 
Biotin-DNA PCR 100 100 100 100  
ATP-biotin reaction and PCR 11 13 9 11 1 
SYBR gold  
 
 
 
 
 
 
SA-Cy5 
 
Trial 2 
 
 
Trial 3 
Trial 2 
 
 
Trial 3 
B. 
A. 
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APPENDIX B: STUDYING THE COSUBSTRATE PROMISCUITY OF LIPID KINASES 
 
Table B.1 - ADP-Glo assay results for 3 independent trials, where kinase catalyzed 
phosphorylatin/ biotinylation was performed on Sph (Figure 3.7.).   
 
 
 
 
 
 
 
 
 
 
 
Tr
ial
 Luminescence signal in arbitrary luminescence units 
1 2 3 4 5 6 7 8 
1 372 583 2019 5003 211157 51462 3512 6428 
2 390 691 2551 11058 184015 46561 2728 7703 
3 316 266 901 4281 222059 52432 3607 13004 
1 2 3  1 2 3  1 2 3 
Figure B.1 – TLC analysis of SPHK1-catalyzed phosphorylation/ biotinylation, 
after a 30 min reaction (Trial 2). Butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) 
mobile phase and Anisaldehyde, Ninhydrin and Molybdenum blue stains were 
used to visualize. Sph (lane 3), ATP reaction (lane 2), ATP-biotin reaction (lane 
3). A trial is shown here, with the second trial shown in Figure 3.8.   
 
çSolvent front 
çSph 
çS1P 
çOrigin (ATP/ATP-
biotin ATP) 	
Molybdenum 
blue	 Anisaldehyde	 Ninhydrin	
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1 2 3 4  1 2 3 4 
1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 
çSolvent front 	
çSph 
çS1P/ S1P biotin 	
çOrigin (ATP/ATP-biotin ATP-BP) 	
Figure B.2 – TLC analysis of SPHK1 catalyzed phosphorylation/ biotinylation / 
benzphonolyzation of Sph after 1 hr incubation at 30 oC. 1-butanol:ethanol:glacial 
acetic acid:H2O (8:2:1:2) mobile phase and Anisaldehyde stain were used to 
visualize.1- ATP-BP reaction, 2- ATP-biotin reaction, 3- ATP reaction, 4- Sph. A trial 
is shown here, with the second trial shown in Figure 3.12. 
 
Trial 2 Trial 3 
Sphè 
çOrigin (ATP/ ATP-
dansyl) 	
çATP-dansyl  
ç (degraded) 	S1Pè 	
Anisaldehyde 	 UV short  (254 nm) 	 UV long (365 nm) 	
Figure B.3 – TLC analysis of SPHK1 catalyzed phosphorylation/ dansylation of Sph 
after 1 hr incubation at 30 oC (Trial 2). A 1-butanol:ethanol:glacial acetic acid:H2O 
(8:2:1:2) mobile phase was  used for separation. Anisaldehyde stain and UV light 
(254 nm and 365 nm) were used to visualize the components. Lanes1,3 - ATP-dansyl  
reaction, Lanes 2, 4- ATP reaction, 5- ATP-dansyl, 6- Sph. The reactions on lanes 1 
and 2 were chloroform extracted before spotting on the TLC plate. A trial is shown 
here, with the second trial shown in Figure 3.13. 
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Compound characterization: ATP-dansyl synthesis 
 
 
Figure B.4- ESI-MS of dansyl amine (8) recorded with methanol solvent. ESI-
MS: m/z calculated for C18H27N3O2S [M+H]+ = 350.2, observed 350.4 
Figure B.5- 1H-NMR of ATP-dansyl (2) recorded in D2O solvent. 
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Figure B.6- MALDI-TOF-MS of ATP-dansyl (2) recorded with 3-HPA matrix. 
MALDI-TOF-MS: m/z calculated for C28H41N8O14P3S [M+H]+ = 839.17, observed 
839.00, m/z calculated for C28H41N8O14P3S [M-H]- = 837.17, observed 837.34 
atp-d 
m/z
834 835 836 837 838 839 840 841 842
%
0
100
m/z
834 835 836 837 838 839 840 841 842
%
0
100
 THILANI 2013_08_23 01 17 (0.307) Cm (2:31) TOF MS LD- 
4.24e3837.34
834.13
835.23
836.12
838.35
838.12
840.12
839.34 842.13841.13
 THILANI 2013_08_23 02 52 (0.905) Cm (2:58) TOF MS LD+ 
1.08e3839.00
834.94
833.80
834.56
834.14
835.88
835.32
837.00
836.53
837.81
838.41
840.00 841.78
841.08
AU
0.00
1.00
2.00
3.00
Minutes
0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00
Figure B.7- Purification of ATP-dansyl (2) by RP-HPLC (buffer A: 0.1M TEAA pH 
7.0, buffer B: Acetonitrile) using a binary system with a gradient of buffer A 95%- 
60% over 40 minutes. The product eluted at 39 min. 
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 1 2 3 4 5 6 7  8 9 10 11 12 13 
Sph + + + + + + +  + + + + - + 
S1P - - - - - - -  - - - - + - 
ATP - - - - + + -  - - + + - - 
ATP-biotin - - + + - - -  - - - - - - 
ATP-O-biotin + + - - - - -  + + - - - - 
SPHK1 - + - + - + -  - + - + - - 
çSolvent front 	
çOrigin (ATP/ ATP-     
biotin analogs) 	
çSph  	
Figure B.8 – TLC analysis of SPHK1 catalyzed phosphorylation/ biotinylation of 
Sph with ATP, ATP-biotn, and ATP-O-biotin. After 1 hr incubation at 30 oC, 1-
butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) mobile phase was used for 
separation. Anisaldehyde stain was used to visualize the speared components. 
Two repetitive trials are shown here, with the first trial shown in Figure 3.15. 
 
 
çS1P 	
Trial 2 	 Trial 3 	
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Compound characterization: ATP-CH2-heptyl (3) synthesis 
  
Figure B.9- 1H-NMR of diethyl heptylphosphonate (10) recorded in DMSO solvent. 
Figure B.10- 13C-NMR of diethyl heptylphosphonate (10) recorded in DMSO solvent 
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Figure B.11- 1H-NMR of heptylphosphonic acid (11) recorded in DMSO solvent. 
 
Figure B.12- 13C-NMR of heptylphosphonic acid (11) recorded in DMSO solvent 
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Figure B.13- HRM-MS of ATP-CH2-heptyl (3) recorded with methanol solvent. 
Figure B.14- 1H-NMR of ATP-CH2-heptyl (3)  recorded in D2O solvent. 
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Figure B.15- 13C-NMR of ATP-CH2-heptyl (3)  recorded in D2O solvent. 
Figure B.16- 31P-NMR of ATP-CH2-heptyl (3)  recorded in D2O solvent. 
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 1 2 3 4 5 6 7  1 2 3 4 5 6 7 
Sph + + + + - - +  + + + + - - + 
S1P - - - - - + -  - - - - - + - 
ATP - - + + - - -  - - + + - - - 
ATP-CH2-heptyl + + - - + - -  + + - - + - - 
SPHK1 + + + + - - -  + + + + - - - 
çSolvent 
front 	
çOrigin 
(ATP/ATP 
analog) 	
çSph  	
çS1P 
products 	
A. B. 
Figure B.17 – TLC analysis of SPHK1 catalyzed phosphorylation/ 
phosphorylheptylation of Sph (Trial 2) with ATP (lane 4) or ATP-CH2-helptyl (lane 2). 
After 1 hr incubation at 30 oC, A 1-butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) 
mobile phase was  used for separation. Anisaldehyde stain was used to visualize the 
separated components. Either A) Crude reactions or B) Chloroform-extracted 
reactions were separated by TLC. A trial is shown here, with the second trial shown 
in Figure 3.16. 
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çSph  	
 
 
 
 
 
 
 
 
 
  
 1 2 3 4 5 6  7 8 9 10 5 6 
Sph + + + + - +  + + + + - + 
S1P - - - - + -  - - - - + - 
ATP + + + + - -  - - - - - - 
ATP-biotin - - - - - -  + + + + - - 
CIP + + - - - -  + + - - - - 
SPHK1 + + + + - -  + + + + - - 
çSolvent front 	
çOrigin 
(ATP/ATP 
analog) 	
çS1P products 	
A. B. 
çSolvent front 	
çOrigin 
(ATP/ATP 
analog) 	
çSph  	
çS1P products 	
A. B. 
Trial 2 
Trial 3 
Figure B.18 – TLC analysis of the effect of phosphatase on SPHK1 catalyzed 
phosphorylation/ phosphobiotinlation of Sph. After kinase catalyzed biotinlation 
followed by CIP treatment the lipids were purified by chloroform extraction. 1-
butanol:ethanol:glacial acetic acid:H2O (8:2:1:2) mobile phase was  used for 
separation. Anisaldehyde stain was used to visualize the speared components. A) 
ATP reaction B) ATP-biotin reaction. Two trials are shown here, with the third trial 
shown in Figure 3.18. 
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Figure B.19 - MAIV data for ATP reaction for Sph in negative mode with 3-NBN 
matrix. [M+H]+ m/z expected values: pure Sph- 300.28 m/z, S1P- 380.24 m/z, S1P- 
808. 49 m/z, Biotin amine- 446.26 m/z. The second trial is shown in Figure 3.19 A 
(bottom).  	
Figure B.20 - MAIV data for ATP-biotin reaction for Sph in negative mode with 3-NBN 
matrix. [M-H]- m/z expected values: Pure Sph- 298.28 m/z, S1P- 378.24 m/z, S1P-
biotin- 807. 49 m/z, Biotin amine- 446.26 m/z). The second trial is shown in Figure 
3.19 A (top).  	
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Figure B.21 - MAIV data for ATP-biotin reaction for Sph in positive mode with 3-NBN 
matrix [M+H]+ m/z expected values: pure Sph- 300.28 m/z, S1P- 380.24 m/z, S1P- 
808. 49 m/z, Biotin amine- 446.26 m/z. The second trial is shown in Figure 3.19. 	
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The kinase family consist of a large assortment of enzymes that phosphorylate a 
variety of substrates, including proteins, nucleosides, polynucleotides, lipids, sugars, 
and other small molecules. The Pflum lab recently found that protein kinases 
promiscuously accept an ATP analog containing a biotin at the γ-phosphate (ATP-
biotin) as a cosubstrate to label the hydroxyl side chains of Ser, Thr and Tyr residues 
with biotin. The main goal of this new project is to extend the use of kinase-catalyzed 
biotinylation towards polynucleotides. Crystallographic studies of T4 polynucleotide 
kinase (T4 PNK) that phosphorylates the 5’-hydroxyl termini of DNA and RNA show a 
solvent exposed ATP binding site, which could facilitate the binding of γ-phosphate 
modified ATP to the enzyme. Based on this analysis, we hypothesize that T4 
polynucleotide kinase could also transfer a phosphobiotinyl group from ATP-biotin to a 
single stranded DNA substrate. Preliminary data are consistent with kinase-catalyzed 
biotinylation. Once validated, kinase-catalyzed biotinylation can be employed as a novel 
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chemical tool to biotinylate the 5’-end of single / double stranded DNA or RNA as an 
alternative to radioactive or chemical labeling. 
Lipids play an important role in cell biology. Lipid kinases phosphorylate a variety 
of lipid molecules, including phosphatidylinositols, ceramides, sphingosines, and 
diacylglycerols.	 To date, our lab has focused entirely on studies of ATP cosubstrate 
promiscuity on protein kinases. The crystallographic analysis of various lipid kinases 
shows solvent exposed binding sites for ATP co-substrate as same as the protein 
kinases, that exhibit co-substrate promiscuity. Based on these facts we hypothesize that 
lipid kinases would also exhibit ATP co-substrate promiscuity. Therefore, an alternative, 
chemical tool is proposed to study lipids, based on kinase-catalyzed labeling in 
understanding lipid based cell signaling. 
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